UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 10-Q

(MARK ONE)

☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the quarterly period ended September 30, ~~2021~~2022

☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

FOR THE TRANSITION PERIOD FROM TO

Commission file number 001-34717

__________________________

Alpha and Omega Semiconductor Limited

(Exact name of Registrant as Specified in its Charter)


Bermuda			77-0553536
(State or Other Jurisdiction of Incorporation or Organization)			(I.R.S. Employer Identification Number)

Clarendon House, 2 Church Street

Hamilton HM 11, Bermuda

(Address of Principal Registered

Offices including Zip Code)

(408) 830-9742

(Registrant's Telephone Number, Including Area Code)

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months, (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes ☒ No ☐

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§ 232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files). Yes ☒ No ☐

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, smaller reporting company or an emerging growth company. See definitions of “large accelerated filer,” “accelerated filer”, “smaller reporting company”, and "emerging growth company" in Rule 12b-2 of the Exchange Act. (Check one):

Large accelerated filer

☐☒

Accelerated filer

☒☐

Non-accelerated filer

☐

(Do not check if a smaller reporting company)

Smaller reporting company

☐

Emerging growth company

☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐


Title of each class	Trading Symbol(s)	Name of each exchange on which registered
Common Shares	AOSL	The NASDAQ Global Select Market

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes ☐ No ☒

Number of common shares outstanding as of October 2231, ~~2021:~~ ~~26,377,519~~2022: 27,407,975~~25,770,998~~25,770,998

Alpha and Omega Semiconductor Limited

Form 10-Q

Fiscal ~~First~~Second Quarter Ended September 30, ~~2021~~2022

TABLE OF CONTENTS


		Page
Part I.	FINANCIAL INFORMATION
Item 1.	Financial Statements:	1
	Condensed Consolidated Balance Sheets as of ~~Sept~~em ~~ber~~ 3 0 ~~, 2021~~September 30, 2022 and June 30, ~~202~~1 2022 (Unaudited)	1
	Condensed Consolidated Statements of ~~Operations~~Income for the Three Months Ended September 3 0 , ~~2021~~2022 and ~~2020~~2021 (Unaudited)	2
	Condensed Consolidated Statements of Comprehensive Income ~~(Loss)~~ for the Three Months Ended September 3 0 , ~~2021~~2022 and ~~2020~~2021 (Unaudited)	3
	Condensed Consolidated Statements of Changes in Equity for the Three Months Ended September 3 0 , ~~2021~~2022 and ~~2020~~2021 (Unaudited)	4
	Condensed Consolidated Statements of Cash Flows for the Three Months Ended September 3 0 , ~~2021~~2022 and ~~2020~~2021 (Unaudited)	5
	Notes to Condensed Consolidated Financial Statements (Unaudited)	6
Item 2.	Management's Discussion and Analysis of Financial Condition and Results of Operations	2829
Item 3.	Quantitative and Qualitative Disclosures About Market Risk	4142
Item 4.	Controls and Procedures	4142
Part II.	OTHER INFORMATION
Item 1.	Legal Proceedings	4243
Item 1A.	Risk Factors	4243
Item 2.	Unregistered Sales of Equity Securities and Use of Proceeds	44
Item 3.	Defaults Upon Senior Securities	45
Item 4.	Mine Safety Disclosures	45
Item 5.	Other Information	45
Item 6.	Exhibits	46
	Signatures	47

PART I. FINANCIAL INFORMATION

ITEM 1. ~~FINANCIAL STATEMENTS~~Financial Statements


ALPHA AND OMEGA SEMICONDUCTOR LIMITED	ALPHA AND OMEGA SEMICONDUCTOR LIMITED					ALPHA AND OMEGA SEMICONDUCTOR LIMITED
CONDENSED CONSOLIDATED BALANCE SHEETS	CONDENSED CONSOLIDATED BALANCE SHEETS					CONDENSED CONSOLIDATED BALANCE SHEETS
(Unaudited, in thousands except par value per share)	(Unaudited, in thousands except par value per share)					(Unaudited, in thousands except par value per share)
		September 30, 2021		June 30, 2021			September 30, 2022		June 30, 2022
ASSETS	ASSETS					ASSETS
Current assets:	Current assets:					Current assets:
Cash and cash equivalents	Cash and cash equivalents	$	252,453	$	202,412	Cash and cash equivalents	$	316,119	$	314,352
Restricted cash	Restricted cash	342		233		Restricted cash	278		299
Accounts receivable, net	Accounts receivable, net	39,317		35,789		Accounts receivable, net	55,769		65,681

Inventories	Inventories	163,437		154,293		Inventories	164,946		158,040

Other current assets	Other current assets	17,518		14,595		Other current assets	11,030		11,220
Total current assets	Total current assets	473,067		407,322		Total current assets	548,142		549,592
Property, plant and equipment, net	Property, plant and equipment, net	441,279		436,977		Property, plant and equipment, net	339,470		318,666
Operating lease right-of-use assets, net		33,437		34,660
Operating lease right-of-use assets						Operating lease right-of-use assets	24,251		23,674
Intangible assets, net	Intangible assets, net	12,570		13,410		Intangible assets, net	9,211		10,050

Equity method investment						Equity method investment	375,914		378,378
Deferred income tax assets						Deferred income tax assets	553		592

Deferred income tax assets		5,216		5,167
Restricted cash - long-term		2,168		2,168
Other long-term assets	Other long-term assets	23,941		18,869		Other long-term assets	13,897		17,677
Total assets	Total assets	$	991,678	$	918,573	Total assets	$	1,311,438	$	1,298,629
LIABILITIES AND EQUITY	LIABILITIES AND EQUITY					LIABILITIES AND EQUITY
Current liabilities:	Current liabilities:					Current liabilities:
Accounts payable	Accounts payable	$	81,681	$	80,699	Accounts payable	$	80,101	$	87,377
Accrued liabilities	Accrued liabilities	92,207		69,494		Accrued liabilities	108,350		116,893
Payable related to equity investee, net						Payable related to equity investee, net	19,516		28,989
Income taxes payable	Income taxes payable	3,004		2,604		Income taxes payable	4,687		4,248
Short-term debt	Short-term debt	57,955		58,030		Short-term debt	26,738		25,563

Finance lease liabilities	Finance lease liabilities	16,722		16,724		Finance lease liabilities	820		802
Operating lease liabilities	Operating lease liabilities	5,537		5,679		Operating lease liabilities	4,119		3,850
Total current liabilities	Total current liabilities	257,106		233,230		Total current liabilities	244,331		267,722
Long-term debt	Long-term debt	75,991		77,990		Long-term debt	46,953		42,486
Income taxes payable - long-term	Income taxes payable - long-term	1,332		1,319		Income taxes payable - long-term	2,191		2,158
Deferred income tax liabilities	Deferred income tax liabilities	3,136		2,448		Deferred income tax liabilities	28,572		28,757
Finance lease liabilities - long-term	Finance lease liabilities - long-term	8,516		12,698		Finance lease liabilities - long-term	3,873		3,932
Operating lease liabilities - long-term	Operating lease liabilities - long-term	29,342		30,440		Operating lease liabilities - long-term	20,748		20,878
Other long-term liabilities	Other long-term liabilities	74,265		44,123		Other long-term liabilities	79,301		78,603
Total liabilities	Total liabilities	449,688		402,248		Total liabilities	425,969		444,536
Commitments and contingencies (Note 10)		0		0
Commitments and contingencies (Note 12)						Commitments and contingencies (Note 12)
Equity:	Equity:					Equity:
Preferred shares, par value $0.002 per share:	Preferred shares, par value $0.002 per share:					Preferred shares, par value $0.002 per share:
Authorized: 10,000 shares; issued and outstanding: none at September 30, 2021 and June 30, 2021		—		—
Authorized: 10,000 shares; issued and outstanding: none at September 30, 2022 and June 30, 2022						Authorized: 10,000 shares; issued and outstanding: none at September 30, 2022 and June 30, 2022	—		—
Common shares, par value $0.002 per share:	Common shares, par value $0.002 per share:					Common shares, par value $0.002 per share:
Authorized: 100,000 shares; issued and outstanding: 32,996 shares and 26,373 shares, respectively at September 30, 2021 and 32,975 shares and 26,350 shares, respectively at June 30, 2021		66		66
Treasury shares at cost: 6,623 shares at September 30, 2021 and 6,625 shares at June 30, 2021		(66,052)		(66,064)
Authorized: 100,000 shares; issued and outstanding: 34,018 shares and 27,401 shares, respectively at September 30, 2022 and 33,988 shares and 27,371 shares, respectively at June 30, 2022						Authorized: 100,000 shares; issued and outstanding: 34,018 shares and 27,401 shares, respectively at September 30, 2022 and 33,988 shares and 27,371 shares, respectively at June 30, 2022	68		68
Treasury shares at cost: 6,617 shares at September 30, 2022 and 6,617 shares at June 30, 2022						Treasury shares at cost: 6,617 shares at September 30, 2022 and 6,617 shares at June 30, 2022	(65,996)		(66,000)
Additional paid-in capital	Additional paid-in capital	264,321		259,993		Additional paid-in capital	299,196		288,951
Accumulated other comprehensive income		2,229		2,315
Accumulated other comprehensive income (loss)						Accumulated other comprehensive income (loss)	(3,827)		1,080
Retained earnings	Retained earnings	200,307		176,895		Retained earnings	656,028		629,994
Total Alpha and Omega Semiconductor Limited shareholder's equity		400,871		373,205
Noncontrolling interest		141,119		143,120

Total equity	Total equity	541,990		516,325		Total equity	885,469		854,093
Total liabilities and equity	Total liabilities and equity	$	991,678	$	918,573	Total liabilities and equity	$	1,311,438	$	1,298,629

See accompanying notes to these condensed consolidated financial statements.

Table of Contents

ALPHA AND OMEGA SEMICONDUCTOR LIMITED

CONDENSED CONSOLIDATED STATEMENTS OF ~~OPERATIONS~~INCOME

(Unaudited, in thousands except per share data)


		Three Months Ended September 30,				Three Months Ended September 30,
		2021		2020				2022		2021
Revenue	Revenue	$	187,035	$	151,551		Revenue	$	208,476	$	187,035
Cost of goods sold	Cost of goods sold	122,468		109,028			Cost of goods sold	137,348		122,468
Gross profit	Gross profit	64,567		42,523			Gross profit	71,128		64,567
Operating expenses	Operating expenses						Operating expenses
Research and development	Research and development	17,812		14,691			Research and development	21,389		17,812
Selling, general and administrative	Selling, general and administrative	21,806		17,505			Selling, general and administrative	24,205		21,806

Total operating expenses	Total operating expenses	39,618		32,196			Total operating expenses	45,594		39,618
Operating income	Operating income	24,949		10,327			Operating income	25,534		24,949
Interest expense and other income (loss), net		(2,192)		(549)
Income before income taxes		22,757		9,778

Other income (loss), net							Other income (loss), net	(16)		(16)
Interest expense, net							Interest expense, net	(608)		(2,176)

Net income before income taxes							Net income before income taxes	24,910		22,757

Income tax expense	Income tax expense	1,320		1,011			Income tax expense	1,374		1,320
Net income including noncontrolling interest		21,437		8,767
Net income before income from equity method investment							Net income before income from equity method investment	23,536		21,437
Equity method investment income from equity investee							Equity method investment income from equity investee	2,502		—
Net income							Net income	26,038		21,437
Net loss attributable to noncontrolling interest	Net loss attributable to noncontrolling interest	(1,987)		(807)			Net loss attributable to noncontrolling interest	—		(1,987)
Net income attributable to Alpha and Omega Semiconductor Limited	Net income attributable to Alpha and Omega Semiconductor Limited	$	23,424	$	9,574		Net income attributable to Alpha and Omega Semiconductor Limited	$	26,038	$	23,424

Net income per common share attributable to Alpha and Omega Semiconductor Limited	Net income per common share attributable to Alpha and Omega Semiconductor Limited						Net income per common share attributable to Alpha and Omega Semiconductor Limited
Basic	Basic	$	0.89	$	0.38		Basic	$	0.95	$	0.89
Diluted	Diluted	$	0.85	$	0.36		Diluted	$	0.88	$	0.85
Weighted average number of common shares attributable to Alpha and Omega Semiconductor Limited used to compute net income per share	Weighted average number of common shares attributable to Alpha and Omega Semiconductor Limited used to compute net income per share						Weighted average number of common shares attributable to Alpha and Omega Semiconductor Limited used to compute net income per share
Basic	Basic	26,365		25,340			Basic	27,391		26,365
Diluted	Diluted	27,638		26,314			Diluted	29,423		27,638

See accompanying notes to these condensed consolidated financial statements.

Table of Contents

ALPHA AND OMEGA SEMICONDUCTOR LIMITED

CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME ~~(LOSS)~~

(Unaudited, in thousands)


		Three Months Ended September 30,				Three Months Ended September 30,
		2021		2020				2022		2021
Net income including noncontrolling interest	Net income including noncontrolling interest	$	21,437	$	8,767		Net income including noncontrolling interest	$	26,038	$	21,437
Other comprehensive income (loss), net of tax
Other comprehensive income, net of tax							Other comprehensive income, net of tax
Foreign currency translation adjustment	Foreign currency translation adjustment	(100)		5,703			Foreign currency translation adjustment	(4,907)		(100)

Comprehensive income	Comprehensive income	21,337		14,470			Comprehensive income	21,131		21,337
Less: Noncontrolling interest	Less: Noncontrolling interest	(2,001)		1,915			Less: Noncontrolling interest	—		(2,001)
Comprehensive income attributable to Alpha and Omega Semiconductor Limited	Comprehensive income attributable to Alpha and Omega Semiconductor Limited	$	23,338	$	12,555		Comprehensive income attributable to Alpha and Omega Semiconductor Limited	$	21,131	$	23,338

See accompanying notes to these condensed consolidated financial statements.

ALPHA AND OMEGA SEMICONDUCTOR LIMITED

CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN EQUITY

(Unaudited, in thousands)

Common Shares
Treasury Stock
Additional Paid-In Capital
Accumulated Other Comprehensive Income (Loss) Retained Earnings
Total AOS Shareholders' Equity Noncontrolling Interest Total Equity
Balance, June 30, 2020 $ 64 $ (66,184) $ 246,103 $ (5,127) $ 118,833 $ 293,689 $ 138,199 $ 431,888
Reissuance of treasury stock upon exercise of common stock options and release of RSUs — 13 — — (13) — — —
Withholding tax on restricted stock units — — (412) — — (412) — (412)
Share-based compensation — — 2,276 — — 2,276 — 2,276
Restricted stock units settlement in connection with service — — 1,000 — — 1,000 — 1,000
Net income (loss) including noncontrolling interest — — — — 9,574 9,574 (807) 8,767
Foreign currency translation adjustment — — — 2,981 — 2,981 2,722 5,703
Balance, September 30, 2020 $ 64 $ (66,171) $ 248,967 $ (2,146) $ 128,394 $ 309,108 $ 140,114 $ 449,222
Common Shares Treasury Stock Additional Paid-In Capital Accumulated Other Comprehensive Income (Loss) Retained Earnings Total AOS Shareholders' Equity Noncontrolling Interest Total Equity
Balance, June 30, 2021 $ 66 $ (66,064) $ 259,993 $ 2,315 $ 176,895 $ 373,205 $ 143,120 $ 516,325
Reissuance of treasury stock upon exercise of common stock options and release of RSUs — 12 — — (12) — — —
Withholding tax on restricted stock units — — (174) — — (174) — (174)
Share-based compensation — — 4,502 — — 4,502 — 4,502
Net income (loss) including noncontrolling interest — — — — 23,424 23,424 (1,987) 21,437
Foreign currency translation adjustment — — — (86) — (86) (14) (100)
Balance, September 30, 2021 $ 66 $ (66,052) $ 264,321 $ 2,229 $ 200,307 $ 400,871 $ 141,119 $ 541,990


	Common Shares		Treasury Stock		Additional Paid-In Capital		Accumulated Other Comprehensive Income (Loss)		Retained Earnings		Total AOS Shareholders' Equity		Noncontrolling Interest		Total Equity
Balance, June 30, 2021	$	66	$	(66,064)	$	259,993	$	2,315	$	176,895	$	373,205	$	143,120	$	516,325

Reissuance of treasury stock upon exercise of common stock options and release of RSUs	—		12		—		—		(12)		—		—		—
Withholding tax on restricted stock units	—		—		(174)		—		—		(174)		—		(174)


Share-based compensation	—		—		4,502		—		—		4,502		—		4,502

Net income (loss) including noncontrolling interest	—		—		—		—		23,424		23,424		(1,987)		21,437
Foreign currency translation adjustment	—		—		—		(86)		—		(86)		(14)		(100)

Balance, September 30, 2021	$	66	$	(66,052)	$	264,321	$	2,229	$	200,307	$	400,871	$	141,119	$	541,990











































	Common Shares		Treasury Stock		Additional Paid-In Capital		Accumulated Other Comprehensive Income (Loss)		Retained Earnings		Total AOS Shareholders' Equity		Noncontrolling Interest		Total Equity
Balance, June 30, 2022	$	68	$	(66,000)	$	288,951	$	1,080	$	629,994	$	854,093	$	—	$	854,093
Exercise of common stock options and release of restricted stock units	—		—		19		—		—		19		—		19
Reissuance of treasury stock upon exercise of common stock options and release of RSUs	—		4		—		—		(4)		—		—		—
Withholding tax on restricted stock units	—		—		(370)		—		—		(370)		—		(370)


Share-based compensation	—		—		10,596		—		—		10,596		—		10,596

Net income	—		—		—		—		26,038		26,038		—		26,038
Foreign currency translation adjustment, net of tax	—		—		—		(4,907)		—		(4,907)		—		(4,907)


Balance, September 30, 2022	$	68	$	(65,996)	$	299,196	$	(3,827)	$	656,028	$	885,469	$	—	$	885,469

See accompanying notes to these condensed consolidated financial statements.

Table of Contents

ALPHA AND OMEGA SEMICONDUCTOR LIMITED

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS

(Unaudited, in thousands)

Three Months Ended September 30,
2021 2020
Cash flows from operating activities
Net income including noncontrolling interest $ 21,437 $ 8,767
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation and amortization 13,722 12,489
Share-based compensation expense 4,635 2,876
Deferred income taxes, net 638 17
Loss on disposal of property and equipment 28 47
Changes in operating assets and liabilities:
Accounts receivable (3,528) (13,044)
Inventories (9,145) (2,172)
Other current and long-term assets (2,561) (1,011)
Accounts payable 2,081 1,930
Income taxes payable 414 749
Accrued and other liabilities 52,886 (800)
Net cash provided by operating activities 80,607 9,848
Cash flows from investing activities
Purchases of property and equipment excluding JV Company (16,642) (7,944)
Purchases of property and equipment in JV Company (8,351) (3,393)
Government grant related to equipment 1,082 —
Net cash used in investing activities (23,911) (11,337)
Cash flows from financing activities
Withholding tax on restricted stock units (174) (412)
Proceeds from borrowings 7,550 11,300
Repayments of borrowings (9,735) (11,085)
Principal payments on finance leases (4,176) (3,989)
Net cash used in financing activities (6,535) (4,186)
Effect of exchange rate changes on cash, cash equivalents and restricted cash (11) 1,997
Net increase (decrease) in cash, cash equivalents and restricted cash 50,150 (3,678)
Cash, cash equivalents and restricted cash at beginning of period 204,813 162,704
Cash, cash equivalents and restricted cash at end of period $ 254,963 $ 159,026
Supplemental disclosures of non-cash investing and financing information:
Property and equipment purchased but not yet paid $ 11,285 $ 6,877


	Three Months Ended September 30,
	2022		2021
Cash flows from operating activities
Net income including noncontrolling interest through December 1, 2021	$	26,038	$	21,437
Adjustments to reconcile net income to net cash provided by operating activities:



Depreciation and amortization	9,352		13,722


Share-based compensation expense	10,596		4,635
Income from equity investment	(2,502)		—

Deferred income taxes, net	(147)		638
Loss on disposal of property and equipment	398		28

Changes in operating assets and liabilities
Accounts receivable	9,912		(3,528)
Inventories	(6,907)		(9,145)
Other current and long-term assets	(519)		(2,561)
Accounts payable	(6,029)		2,081
Net payable equity investee	(9,472)		—
Income taxes payable	471		414

Accrued and other liabilities	5,484		52,886
Net cash provided by operating activities	36,675		80,607
Cash flows from investing activities


Purchases of property and equipment	(40,260)		(24,993)







Government grant related to equipment	286		1,082
Net cash used in investing activities	(39,974)		(23,911)
Cash flows from financing activities
Withholding tax on restricted stock units	(370)		(174)
Proceeds from exercise of stock options and release of restricted stock	19		—


Proceeds from borrowings	8,632		7,550
Repayments of borrowings	(2,618)		(9,735)
Principal payments on finance leases	(201)		(4,176)
Net cash provided by (used in) financing activities	5,462		(6,535)
Effect of exchange rate changes on cash, cash equivalents and restricted cash	(417)		(11)
Net increase in cash, cash equivalents and restricted cash	1,746		50,150
Cash, cash equivalents and restricted cash at beginning of period	314,651		204,813
Cash, cash equivalents and restricted cash at end of period	$	316,397	$	254,963

Supplemental disclosures of non-cash investing and financing information:
Property and equipment purchased but not yet paid	$	19,360	$	11,285

	September 30, 2022		September 30, 2021
Reconciliation of cash, cash equivalents, and restricted cash:
Cash and cash equivalents	$	316,119	$	252,453
Restricted cash	278		342
Restricted cash - long term	—		2,168
Total cash, cash equivalents, and restricted cash	$	316,397	$	254,963

See accompanying notes to these condensed consolidated financial statements.

ALPHA AND OMEGA SEMICONDUCTOR LIMITED

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(Unaudited)

1. The Company and Significant Accounting Policies

The Company

Alpha and Omega Semiconductor Limited and its subsidiaries (the “Company”, “AOS”, “we” or “us”) design, develop and supply a broad range of power semiconductors. The Company's portfolio of products targets high-volume applications, including personal and portable computers, graphic cards, flat panel TVs, home appliances, smart phones, battery packs, quick chargers, home appliances, consumer and industrial motor controls and power supplies for TVs, computers, servers and telecommunications equipment. The Company conducts its operations primarily in the United States of America (“USA”), Hong Kong, China, and South Korea.

Basis of Preparation

The accompanying unaudited ~~condensed consolidated financial statements~~Condensed Consolidated Financial Statements have been prepared in accordance with accounting principles generally accepted in the United States (“U.S. GAAP”) for interim financial information and with the instructions to Article 10 of Securities and Exchange Commission Regulation S-X, as amended. They do not include all information and footnotes necessary for a fair presentation of financial position, results of operations and cash flows in conformity with U.S. GAAP for complete financial statements. These ~~condensed consolidated financial statements~~Condensed Consolidated Financial Statements should be read in conjunction with the consolidated financial statements and related notes contained in the Company’s Annual Report on Form 10-K for the fiscal year ended June 30, ~~2021.~~2022. All significant intercompany balances and transactions have been eliminated in consolidation. In the opinion of management, all adjustments (consisting of normal recurring adjustments and accruals) considered necessary for a fair presentation of the results of operations for the periods presented have been included in the interim periods. Operating results for the three months ended September 30, ~~2021~~2022 are not necessarily indicative of the results that may be expected for the fiscal year ending June 30, ~~2022~~2023 or any other interim period. The consolidated balance sheet at June 30, ~~2021~~2022 is derived from the audited financial statements included in the Company’s Annual Report on Form 10-K for the fiscal year ended June 30, ~~2021.~~

~~Reclassification~~

The Company has reclassified certain amounts previously reported in its financial statements to conform to the current presentation. These reclassifications did not have a material impact on our condensed consolidated financial statements.2022.

Joint Venture

On March 29, 2016, the Company entered into a joint venture contract (the “JV Agreement”) with two investment funds owned by the Municipality of Chongqing (the “Chongqing Funds”), pursuant to which the Company and the Chongqing Funds formed a joint venture, (the “JV Company”), for the purpose of constructing and operating a power semiconductor packaging, testing and 12-inch wafer fabrication facility ~~(“Fab”)~~ in the ~~LiangJiang~~Liangjiang New Area of Chongqing, China (the “JV Transaction”). ~~The Fab is being built in phases.~~ As of ~~September 30,~~December 1, 2021, the Company owned ~~51%~~50.9%, and the Chongqing Funds owned ~~49%~~49.1%, of the equity interest in the JV Company. The Joint Venture iswas accounted under the provisions of the consolidation guidance since the Company ~~has~~had controlling financial ~~interest. If both parties agree~~interest until December 1, 2021. As of December 2, 2021, the Company ceased having control over the JV Company. Therefore, the Company deconsolidated the JV Company as of that date. Subsequently, the ~~termination~~Company has accounted for its investment in the JV Company using the equity method of accounting. As of September 30, 2022, the percentage of outstanding JV equity interest beneficially owned by the Company was reduced to 42.2%. Such reduction reflects (i) the sale by the Company of approximately 2.1% of the outstanding JV equity interest which resulted in the deconsolidation of the JV Company, is(ii) additional sale by the ~~best~~Company of approximately 1.1% of outstanding JV equity interest in December 2021, (iii) the adoption of ~~each party or the JV Company is bankrupt or insolvent where either party may terminate early, after paying the debts~~an employee equity incentive plan and issued an equity interest equivalent to 3.99% of the JV Company in exchange for cash in December 2021, and (iv) the ~~remaining assets~~New Investors purchased newly issued equity interest of ~~the~~ JV Company shall be paid to the Chongqing Funds to cover the principal of its total paid-in contributions plus interest at 10% simple annual rate prior to distributing the balance of the JV Company’s assets to the Company. The JV Company has reached its targeted production in ~~assembly and testing and completed the ramp on its Phase I of the 12-inch wafer fabrication.~~January 2022.

Certain Significant Risks and Uncertainties Related to Outbreak of Coronavirus Disease 2019 (“COVID-19”)

~~The COVID-19 pandemic has had and continues to have a negative impact on business and economic activities across the globe.~~ As a result of the COVID-19 pandemic and ~~the global economic downturn and~~ changing consumer behaviors due to various government restrictions ~~imposed~~and the growing trend to provide remote-working options by ~~governments,~~employers, the Company has experienced shifting market trends, including an increasing demand in ~~the~~ markets for notebooks, ~~PCs and~~personal computing ("PC"), gaming devices and ~~decreasing demand for mobile phone and industrial products, as more consumers are staying at and working from home.~~other products. While ~~the Company~~it has ~~recently~~ benefited from the increasing demand offor PC related products, there is no guarantee that this trend will continue, and such increasing demand may discontinue or decline if government authorities relax or terminate COVID-19 related restrictions and consumer behaviors change in response to the reopening of certain economic activities. During the first half of calendar year 2022, COVID-19 cases and hospitalization rate continued to decline and governments in various jurisdictions, including the U.S. and Europe, have lifted various restrictions and limitations on economic activities. At the same time,

ALPHA AND OMEGA SEMICONDUCTOR LIMITED

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(Unaudited)

~~discontinue or decline as government authorities relax~~however, new variants of COVID-19 continued to emerge and terminate COVID-19 related restrictions and consumer behaviors change. Furthermore, as the COVID-19 pandemic continues and global economic downturn and high unemployment persists, consumer spending may slow down substantially,contributed to recent rise of infection rates in various jurisdictions in which ~~case~~we operate, including China and U.S. Furthermore, the Company may ~~experience a significant decline~~be subject to the ongoing global impacts resulting from the pandemic, including disruption of ~~customer orders for its products, including those designed for PC-related applications,~~the product supply chains, shortages of semiconductor components, and ~~such decline will adversely affect its financial conditions~~delays in shipments, product development, and ~~results~~product launches and rising inflation rates. In addition, the Company’s operations in China have been negatively impacted by the zero-Covid policy imposed by the Chinese government, which has resulted in lockdowns, mass testing and restrictions of ~~operations.~~ travels and movement that limited our ability to conduct our business activities.

The full extent of the ~~future~~longer-term impact of the COVID-19 pandemic on the Company’s operational and financial performance is ~~currently~~ uncertain and will depend on many factors outside ~~the Company’s~~of its control, including, without limitation, the timing, extent, trajectory and duration of the pandemic; the availability, distribution and effectiveness of vaccines; the spread of new variants of COVID-19; the continued orand renewed imposition of protective public safety ~~measures;~~measures, including local and regional lockdown and quarantines; the ~~continuing~~ disruption of global supply ~~chain affecting the semiconductor industry;~~chain; and the impact of the pandemic on the global economy and demand for consumer products.

Use of Estimates

The preparation of the ~~condensed~~ consolidated financial statements in conformity with U.S. GAAP requires the Company to make estimates, judgments and assumptions that affect the reported amounts of assets, liabilities, revenue and expenses. To the extent there are material differences between these estimates and actual results, the Company's condensed consolidated financial statements will be affected. On an ongoing basis, the Company evaluates the estimates, judgments and assumptions including those related to stock rotation returns, price adjustments, allowance for doubtful accounts, inventory reserves, warranty accrual, income taxes, leases, share-based compensation, recoverability of and useful lives for property, plant and equipment and intangible assets, as well as the economic implications of the COVID-19 pandemic.

Leases

The Company determines if an arrangement is a lease at inception. Operating leases are included in operating lease right-of-use (“ROU”) assets, current operating lease liabilities and long-term operating lease liabilities on the Company's ~~condensed consolidated balance sheets.~~Condensed Consolidated Balance Sheets. Finance leases are included in property, plant and equipment, finance lease liabilities and long-term finance leases liabilities on the ~~condensed consolidated balance sheets.~~Condensed Consolidated Balance Sheets.

Operating lease ROU assets and operating lease liabilities are recognized based on the present value of the future minimum lease payments over the lease term at commencement date. The Company uses an estimate of its incremental borrowing rate based on the information available at the lease commencement date. The operating lease ROU assets also include any lease payments made and exclude lease incentives. Lease terms may include options to extend or terminate the lease when it is reasonably certain that the Company will exercise such options. Operating lease expense is generally recognized on a straight-line basis over the lease term. Variable lease payments are expensed as incurred and are not included within the operating lease ROU asset and lease liability calculation. The Company does not record leases on the ~~condensed consolidated balance sheet~~Condensed Consolidated Balance Sheet with a term of one year or less. The Company elected to combine its lease and non-lease components as a single lease component for all asset classes.

Revenue recognition

The Company determines revenue recognition through the following steps: (1) identification of the contract with a customer; (2) identification of the performance obligations in the contract; (3) determination of the transaction price; (4) allocation of the transaction price to the performance obligations in the contract; and (5) recognition of revenue when, or as, a performance obligation is satisfied. The Company recognizes product revenue at a point in time when product is shipped to the customer, net of estimated stock rotation returns and price adjustments that it expects to provide to certain distributors. The Company presents revenue net of sales taxes and any similar assessments. Our standard payment terms range from 30 to 9060 days.

The Company sells its products primarily to distributors, who in turn sell the products globally to various end customers. The Company allows stock rotation returns from certain distributors. Stock rotation returns are governed by contract and are limited to a specified percentage of the monetary value of products purchased by distributors during a specified period. The Company records an allowance for stock rotation returns based on historical returns and individual distributor agreements. The Company also provides special pricing to certain distributors, primarily based on volume, to encourage resale of the Company’s products. Allowance for price adjustments is recorded against accounts receivable and the provision for stock rotation rights is included in accrued liabilities on the ~~condensed consolidated balance sheets.~~Condensed Consolidated Balance Sheets.

ALPHA AND OMEGA SEMICONDUCTOR LIMITED

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(Unaudited)

The Company’s performance obligations relate to contracts with a duration of less than one year. The Company elected to apply the practical expedient provided in ASC 606, “Revenue from Contracts with Customers”. Therefore, the Company is not

~~ALPHA AND OMEGA SEMICONDUCTOR LIMITED~~

~~NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS~~

~~(Unaudited)~~

required to disclose the aggregate amount of transaction price allocated to performance obligations that are unsatisfied or partially unsatisfied at the end of the reporting period.

The Company recognizes the incremental direct costs of obtaining a contract, which consist of sales commissions, when control over the products they relate to transfers to the customer. Applying the practical expedient, the Company recognizes commissions as expense when incurred, as the amortization period of the commission asset the Company would have otherwise recognized is less than one year.

Packaging and testing services revenue is recognized at a point in time upon shipment of serviced products to the customer.

Share-based Compensation Expense

The Company maintains an equity-settled, share-based compensation plan to grant restricted share units and stock options. The Company recognizes expense related to share-based compensation awards that are ultimately expected to vest based on estimated fair values on the date of grant. The fair value of restricted share units is based on the fair value of the Company's common share on the date of grant. For restricted stock awards subject to market conditions, the fair value of each restricted stock award is estimated at the date of grant using the Monte-Carlo pricing model. The fair value of stock options is estimated on the date of grant using the Black-Scholes option valuation model. Share-based compensation expense is recognized on the accelerated attribution basis over the requisite service period of the award, which generally equals the vesting period. The Employee Share Purchase Plan (the “ESPP”) is accounted for at fair value on the date of grant using the Black-Scholes option valuation model.

Restricted Cash

~~As a condition of certain loan agreement, the Company is required to keep a compensating balance at the issuing bank (see Note 5). In addition, the~~The Company maintains restricted cash in connection with cash balances temporarily restricted for regular business operations, including the possibility of a dispute with a vendor. These balances have been excluded from the Company’s cash and cash equivalents balance and are classified as restricted cash in the Company’s ~~condensed consolidated balance sheets.~~Condensed Consolidated Balance Sheets. As of September 30, ~~2021~~2022 and June 30, ~~2021,~~2022, the amount of restricted cash was ~~$2.5~~$0.3 million and ~~$2.4~~$0.3 million, respectively.

Equity method investment

The Company uses the equity method of accounting when it has the ability to exercise significant influence, but not control, as determined in accordance with generally accepted accounting principles, over the operating and financial policies of the investee. Effective December 2, 2021, the Company reduced its equity interest in the JV Company and experienced a loss of control of the JV Company. As a result, beginning December 2, 2021, the Company records its investment under equity method of accounting. Since the Company is unable to obtain accurate financial information from the JV Company in a timely manner, the Company records its share of earnings or losses of such affiliate on a one quarter lag. The Company discloses and recognizes intervening events at the JV Company in the lag period that could materially affect our consolidated financial statements, if applicable.

The Company records its interest in the net earnings of the equity method investee, along with adjustments for unrealized profits or losses on intra-entity transactions and amortization of basis differences, within earnings or loss from equity interests in the Consolidated Statements of Income. Profits or losses related to intra-entity sales with the equity method investee are eliminated until realized by the investor and investee. Basis differences represent differences between the cost of the investment and the underlying equity in net assets of the investment and are generally amortized over the lives of the related assets that gave rise to them. Equity method goodwill is not amortized or tested for impairment; instead the equity method investment is tested for impairment. The Company reviews for impairment whenever factors indicate that the carrying amount of the investment might not be recoverable. In such a case, the decrease in value is recognized in the period the impairment occurs in the Condensed Consolidated Statements of Income.

Valuation of inventories

The Company carries inventories at the lower of cost (determined on a first-in, first-out basis) or net realizable value. Cost primarily consists of semiconductor wafers and raw materials, labor, depreciation expenses and other manufacturing expenses

ALPHA AND OMEGA SEMICONDUCTOR LIMITED

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(Unaudited)

and overhead, and packaging and testing fees paid to third parties if subcontractors are used. Valuation of inventories is based on its periodic review of inventory quantities on hand as compared with its sales forecasts, historical usage, aging of inventories, production yield levels and current product selling prices. If actual market conditions are less favorable than those forecasted by the Company, additional future inventory write-downs may be required that could adversely affect its operating results. Adjustments to inventory, once established are not reversed until the related inventory has been sold or scrapped. If actual market conditions are more favorable than expected and the products that have previously been written down are sold, our gross margin would be favorably impacted.

Fair Value of Financial Instruments

The fair value of cash equivalents is categorized in Level 1 in the fair value hierarchy. Cash equivalents consist primarily of short-term bank deposits. The carrying values of financial instruments such as cash and cash equivalents, accounts receivable and accounts payable approximate their carrying values due to their short-term maturities. The carrying value of the ~~company's~~Company's debt is considered a reasonable estimate of fair value which is estimated by considering the current rates available to the Company for debt of the same remaining maturities, structure, credit risk and terms of the debts.

Government Grants

The Company occasionally receives government grants that provide financial assistance for certain eligible expenditures in China. These grants include reimbursements on interest expense on bank borrowings, payroll tax credits, credit for property, plant and equipment in a particular geographical location, employment credits, as well as business expansion credits. Government grants are not recognized until there is reasonable assurance that the Company will comply with the conditions attaching to it, and that the grant will be received. The Company records such grants either as a reduction of the related expense, a reduction of the cost of the related asset, or as other income depending upon the nature of the grant. As a result of such grants, during the three months ended September 30, 2022 and 2021, the Company reduced ~~the carrying value of~~ property, plant and equipment by ~~$1.1 million. During the three months ended September 30, 2020, the Company reduced interest expense by $0.8~~$0.3 million, and ~~operating expenses by $1.9~~$1.1 million, respectively.

~~Long-lived Assets~~Accounting for income taxes

Income tax expense or benefit is based on income or loss before taxes. Deferred tax assets and liabilities are recognized principally for the expected tax consequences of temporary differences between the tax basis of assets and liabilities and their reported amounts.

The Company ~~evaluates its long-lived~~is subject to income taxes in a number of jurisdictions. Significant judgment is required in determining the worldwide provision for income taxes. There are many transactions and calculations for which the ultimate tax determination is uncertain during the ordinary course of business. The Company establishes accruals for certain tax contingencies based on estimates of whether additional taxes may be due. While the final tax outcome of these matters may differ from the amounts that were initially recorded, such differences will impact the income tax and deferred tax provisions in the period in which such determination is made.

Significant management judgment is also required in determining whether deferred tax assets will be realized in full or in part. When it is more likely than not that all or some portion of specific deferred tax assets such as net operating losses or research and experimentation tax credit carryforwards will not be realized, a valuation allowance must be established for ~~impairment whenever events or changes indicate that~~ the ~~carrying~~ amount of the deferred tax assets that cannot be realized. The Company considers all available positive and negative evidence on a jurisdiction-by-jurisdiction basis when assessing whether it is more likely than not that deferred tax assets are recoverable. The Company considers evidence such ~~assets may~~as our past operating results, the existence of cumulative losses in recent years and our forecast of future taxable income.

The Financial Accounting Standards Board (FASB), issued guidance which clarifies the accounting for income taxes by prescribing a minimum probability threshold that a tax position must meet before a financial statement benefit is recognized. The minimum threshold is defined as a tax position that is more likely than not to be ~~recoverable. Due~~sustained upon examination by the applicable taxing authority, including resolution of any related appeals or litigation processes, based on the technical merits of the position. The tax benefit to be recognized is measured as the ~~COVID-19 pandemic,~~largest amount of benefit that is greater than fifty percent likely to be realized upon ultimate settlement. Although the ~~Company assessed~~guidance on the ~~changes~~accounting for uncertainty in ~~circumstances that occurred during~~income taxes prescribes the ~~March~~use of a recognition and ~~June 2020 quarters. These factors included continued operating losses,~~measurement model, the determination of whether an uncertain tax position has met those thresholds will continue to require significant judgment by management. If the ultimate resolution of tax uncertainties is different from what is currently estimated, a ~~decrease in the~~material impact on income tax expense could result.

ALPHA AND OMEGA SEMICONDUCTOR LIMITED

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(Unaudited)

The Company's ~~share price~~provision for income taxes is subject to volatility and could be adversely impacted by changes in ~~February~~earnings or tax laws and ~~March~~regulations in various jurisdictions. The Company is subject to the continuous examination of ~~2020, which reduced its market capitalization, expectation~~our income tax returns by the Internal Revenue Service and other tax authorities. The Company regularly assesses the likelihood of ~~lower business growth~~adverse outcomes resulting from these examinations to determine the adequacy of our provision for income taxes. To the ~~coming quarters, increased and prolonged economic and regulatory uncertainty~~extent that the final tax outcome of these matters is different from the amounts recorded, such differences will impact the provision for income taxes in the ~~global economies,~~period in which such determination is made. The provision for income taxes includes the impact of changes to reserves, as well as the related net interest and ~~the expectation of higher supply chain costs and increased competition. Therefore,~~penalties.

Long-lived Assets

The Company reviews all long-lived assets whenever events or changes in circumstance indicate that these assets may not be recoverable. When evaluating long-lived assets, if the Company ~~performed a recoverability test by comparing the sum of~~concludes that the estimated undiscounted ~~future~~ cash flows ~~of its long-lived~~attributable to the assets toare less than their carrying amount as of June 30, 2020. Some of the more significant assumptions used in the estimated future cash flows involve net sales, cost of goods sold, operating expenses, working capital, capital expenditures, income tax rates, long-term growth rates that appropriately reflect the risks inherent in the future cash flow stream and terminal value. The Company selected the assumptions used in the financial forecasts by referencing to historical data, supplemented by current and anticipated market conditions, estimated product growth rates and management's plans. These estimated future cash flows were consistent with thosevalue, the Company ~~uses in its internal planning. The result~~recognizes an impairment loss based on the excess of ~~the recoverability test indicated that the sum of the expected future cash flows (undiscounted and without interest charges) was greater than~~ the carrying amount of the ~~long-lived assets. Therefore, the Company concluded that the carrying amount~~assets over their respective fair values, which could adversely affect its results of ~~the long-lived assets is recoverable as of June 30, 2021.~~operations.

Comprehensive Income ~~(Loss)~~

Comprehensive income ~~(loss)~~ is defined as the change in equity of a business enterprise during a period from transactions and other events and circumstances from non-owner sources. The Company's accumulated other comprehensive income ~~(loss)~~ consists of cumulative foreign currency translation adjustments. Total comprehensive income ~~(loss)~~ is presented in the ~~condensed consolidated statements~~Condensed Consolidated Statements of ~~comprehensive income (loss).~~Comprehensive Income.

Recent Accounting Pronouncements

Recently Issued Accounting Standards not yet adopted

In ~~August 2020,~~September 2022, the Financial Accounting Standards Board (FASB) issued Accounting Standards Update (ASU) No. 2022-04, "Supplier Finance Programs (Subtopic 405-50): Disclosure of Supplier Finance Program Obligations". This ASU was issued in response to requests from financial statement users for increased transparency surrounding the use of supplier finance programs. The amendments in ASU 2022-04 require that a buyer in a supplier finance program disclose sufficient information about the program to allow a user of financial statements to understand the program’s nature, activity during the period, changes from period to period, and potential magnitude. The amendments in this ASU do not affect the recognition, measurement, or financial statement presentation of obligations covered by supplier finance programs. The amendments in this ASU are effective for fiscal years beginning after December 15, 2022, including interim periods within those fiscal years, except for the amendment on rollforward information, which is effective for fiscal years beginning after December 15, 2023. Early adoption is permitted. The Company is currently evaluating the impact of adopting this guidance.

Recently Adopted Accounting Standards

In November 2021, the FASB issued Accounting Standards Update (ASU) No. 2021-10, Government Assistance (Topic 832): Disclosures by Business Entities about Government Assistance. This ASU requires business entities to make annual disclosures about transactions with a government they account for by analogizing to a grant or contribution accounting model under ASC 958-605. The adoption of ASU 2021-10 had no impact on the Company's Consolidated Financial Statements.

In August 2020, the FASB issued ASU No. 2020-06, Debt—Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging—Contracts in Entity’s Own Equity (Subtopic 815-40): Accounting for Convertible Instruments and Contracts in an Entity’s Own Equity, which, among other things, provides guidance on how to account for contracts on an entity’s own equity. This ASU simplifies the accounting for certain financial instruments with characteristics of liabilities and equity. Specifically, the ASU eliminated the need for the Company to assess whether a contract on the entity’s own equity (1) permits settlement in unregistered shares, (2) whether counterparty rights rank higher than shareholder’s rights, and (3) whether collateral is required. In addition, the ASU requires incremental disclosure related to contracts on the entity’s own equity and clarifies the treatment of certain financial instruments accounted for under this ASU on earnings per share. ~~For public business entities, the ASU is effective for fiscal years beginning after December 15, 2021, and interim periods within those fiscal years.~~ The ~~Company does not expect the~~ adoption of ~~this guidance will have a material impact on its consolidated financial position, results of operations or cash flows.~~

~~Recently Adopted Accounting Standards~~

~~In January 2020, the FASB issued~~ ASU No. 2020-01, “Investments - Equity Securities (Topic 321), Investments - Equity Method and Joint Ventures (Topic 323), and Derivatives and Hedging (Topic 815) - Clarifying the Interactions between Topic 321, Topic 323, and Topic 815.” The ASU is based on a consensus of the Emerging Issues Task Force and is expected to increase comparability in accounting for these transactions. ASU 2016-01 made targeted improvements to accounting for financial instruments, including providing an entity the ability to measure certain equity securities without a readily determinable fair value at cost, less any impairment, plus or minus changes resulting from observable price changes in orderly transactions for the identical or a similar investment of the same issuer. Among other topics, the amendments clarify that an entity should consider observable transactions that require it to either apply or discontinue the equity method of accounting. ASU 2020-012020-06 had no ~~material~~ impact on the Company's ~~consolidated financial statements.~~

In December 2019, the FASB issued ASU No. 2019-12 “Income Taxes (Topic 740): Simplifying the Accounting for Income Taxes ("ASU 2019-12") by removing certain exceptions to the general principles. The Company adopted ASU 2019-12 as of July 1, 2021. ASU 2019-12 had no material impact on the Company's consolidated financial statements.

Consolidated Financial Statements.

910

ALPHA AND OMEGA SEMICONDUCTOR LIMITED

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(Unaudited)

2. Equity Method Investment in Equity Investee

On December 1, 2021 (the “Effective Date”), Alpha & Omega Semiconductor (Shanghai) Ltd. (“AOS SH”) and Agape Package Manufacturing (Shanghai) Limited (“APM SH” and, together with AOS SH, the “Sellers”), each a wholly-owned subsidiary of the Company, entered into a share transfer agreement ("STA") with a third-party investor to sell a portion of the Company's equity interest in the JV Company which consists of a power semiconductor packaging, testing and 12-inch wafer fabrication facility in Chongqing, China (the “Transaction”). The Transaction closed on December 2, 2021 (the “Closing Date”), which reduced the Company’s equity interest in the JV Company from 50.9% to 48.8%. Also, the Company’s right to designate directors on the board of JV Company was reduced to three (3) out of seven (7) directors, from four (4) directors prior to the Transaction. As a result of the Transaction and other factors, the Company no longer has a controlling financial interest in the JV Company and has determined that the JV Company was deconsolidated from the Company’s Consolidated Financial Statements effective as of the Closing Date.

On December 24, 2021, the Company entered into a share transfer agreement with another third-party investor, pursuant to which the Company sold to this investor 1.1% of outstanding equity interest held by the Company in the JV Company. In addition, the JV Company adopted an employee equity incentive plan and issued an equity interest equivalent to 3.99% of the JV Company in exchange to cash. As a result of these two transactions, the Company owned 45.8% of the equity interest in the JV Company as of December 31, 2021.

On January 26, 2022, the JV Company completed a financing transaction pursuant to a corporate investment agreement (the “Investment Agreement”) between the JV Company and certain third-party investors (the “New Investors”). Under the Investment Agreement, the New Investors purchased newly issued equity interest of the JV Company, representing approximately 7.82% of post-transaction outstanding equity interests of the JV Company, for a total purchase price of RMB 509 million (or approximately USD 80 million based on the currency exchange rate as of January 26, 2022) (the “Investment”). Following the closing of the Investment and as of June 30, 2022, the percentage of outstanding JV equity interest beneficially owned by the Company was reduced to 42.2%.

The Company accounts for its investment in the JV Company as an equity method investment and reports its equity in earnings or loss of the JV Company on a three-month lag due to an inability to timely obtain financial information of the JV Company. During the three months ended September 30, 2022, the Company recorded $2.5 million of its equity in income of the JV Company, using lag reporting. As of September 30, 2022, the percentage of outstanding JV equity interest beneficially owned by the Company was 42.2%.

ALPHA AND OMEGA SEMICONDUCTOR LIMITED

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(Unaudited)

3. Related Party Transactions

As of September 30, 2022, the Company owned 42.2% equity interest in the JV Company, which, by definition, is a related party to the Company. The JV Company supplies 12-inch wafers and provides assembly and testing services to AOS. AOS also sells 8-inch wafers to the JV Company for further assembly and testing services. Due to the right of offset of receivables and payables with the JV Company, as of September 30, 2022, AOS recorded the net amount of $19.5 million presented as payable related to equity investee, net, in the Condensed Consolidated Balance Sheet. Since the December 2, 2021 deconsolidation of the JV Company, the purchases by AOS for the three months ended September 30, 2022 were $46.1 million, and the sales by AOS for the three months ended September 30, 2022 were $16.6 million.

ALPHA AND OMEGA SEMICONDUCTOR LIMITED

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(Unaudited)

4. Net Income Per Common Share Attributable to Alpha and Omega Semiconductor Limited

The following table presents the calculation of basic and diluted net income per share attributable to common shareholders:


		Three Months Ended September 30,					Three Months Ended September 30,
		2021		2020					2022		2021
		(in thousands, except per share data)				(in thousands, except per share data)
Numerator:	Numerator:							Numerator:
Net income attributable to Alpha and Omega Semiconductor Limited	Net income attributable to Alpha and Omega Semiconductor Limited	$	23,424	$	9,574			Net income attributable to Alpha and Omega Semiconductor Limited	$	26,038	$	23,424

Denominator:	Denominator:							Denominator:
Basic:	Basic:							Basic:
Weighted average number of common shares used to compute basic net income per share	Weighted average number of common shares used to compute basic net income per share	26,365		25,340				Weighted average number of common shares used to compute basic net income per share	27,391		26,365
Diluted:	Diluted:							Diluted:
Weighted average number of common shares used to compute basic net income per share	Weighted average number of common shares used to compute basic net income per share	26,365		25,340				Weighted average number of common shares used to compute basic net income per share	27,391		26,365
Effect of potentially dilutive securities:	Effect of potentially dilutive securities:							Effect of potentially dilutive securities:
Stock options, RSUs and ESPP shares	Stock options, RSUs and ESPP shares	1,273		974				Stock options, RSUs and ESPP shares	2,032		1,273
Weighted average number of common shares used to compute diluted net income per share	Weighted average number of common shares used to compute diluted net income per share	27,638		26,314				Weighted average number of common shares used to compute diluted net income per share	29,423		27,638
Net income per share attributable to Alpha and Omega Semiconductor Limited:	Net income per share attributable to Alpha and Omega Semiconductor Limited:							Net income per share attributable to Alpha and Omega Semiconductor Limited:
Basic	Basic	$	0.89	$	0.38			Basic	$	0.95	$	0.89
Diluted	Diluted	$	0.85	$	0.36			Diluted	$	0.88	$	0.85

The following potential dilutive securities were excluded from the computation of diluted net income per share as their effect would have been anti-dilutive:


		Three Months Ended September 30,		Three Months Ended September 30,
		2021	2020			2022	2021
		(in thousands)		(in thousands)
Employee stock options and RSUs	Employee stock options and RSUs	510	124		Employee stock options and RSUs	605	510
ESPP	ESPP	33	233		ESPP	223	33
Total potential dilutive securities	Total potential dilutive securities	543	357		Total potential dilutive securities	828	543

ALPHA AND OMEGA SEMICONDUCTOR LIMITED

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(Unaudited)

5. Concentration of Credit Risk and Significant Customers

The Company manages its credit risk associated with exposure to distributors and direct customers on outstanding accounts receivable through the application and review of credit approvals, credit ratings and other monitoring procedures. In some instances, the Company also obtains letters of credit from certain customers.

Credit sales, which are mainly on credit terms of 30 to 60 days, are only made to customers who meet the Company's credit requirements, while sales to new customers or customers with low credit ratings are usually made on an advance payment basis. The Company considers its trade accounts receivable to be of good credit quality because its key distributors and direct customers have long-standing business relationships with the Company and the Company has not experienced any significant bad debt write-offs of accounts receivable in the past. The Company closely monitors the aging of accounts receivable from its distributors and direct customers, and regularly reviews their financial positions, where available.

Summarized below are individual customers whose revenue or accounts receivable balances were 10% or higher than the respective total consolidated amounts:

~~ALPHA AND OMEGA SEMICONDUCTOR LIMITED~~

~~NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS~~

~~(Unaudited)~~


		Three Months Ended September 30,				Three Months Ended September 30,
Percentage of revenue	Percentage of revenue	2021		2020			Percentage of revenue	2022		2021
Customer A	Customer A	27.4	%	28.8	%		Customer A	24.0	%	27.4	%
Customer B	Customer B	36.6	%	33.1	%		Customer B	38.6	%	36.6	%

Customer C							Customer C	11.2	%	*


		September 30, 2021		June 30, 2021			September 30, 2022		June 30, 2022
Percentage of accounts receivable	Percentage of accounts receivable					Percentage of accounts receivable
Customer A	Customer A	16.0	%	12.4	%	Customer A	13.3	%	24.6	%
Customer B	Customer B	17.3	%	22.1	%	Customer B	30.7	%	36.4	%

Customer C	Customer C	18.2	%	21.9	%	Customer C	18.7	%	12.0	%

* Less than 10%

1114

ALPHA AND OMEGA SEMICONDUCTOR LIMITED

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(Unaudited)

4.6. Balance Sheet Components

Accounts receivable, net:


		September 30, 2021		June 30, 2021			September 30, 2022		June 30, 2022
		(in thousands)					(in thousands)
Accounts receivable	Accounts receivable	$	53,017	$	48,234	Accounts receivable	$	77,802	$	84,442
Less: Allowance for price adjustments	Less: Allowance for price adjustments	(13,670)		(12,415)		Less: Allowance for price adjustments	(22,003)		(18,731)
Less: Allowance for doubtful accounts	Less: Allowance for doubtful accounts	(30)		(30)		Less: Allowance for doubtful accounts	(30)		(30)
Accounts receivable, net	Accounts receivable, net	$	39,317	$	35,789	Accounts receivable, net	$	55,769	$	65,681

Inventories:


		September 30, 2021		June 30, 2021			September 30, 2022		June 30, 2022
		(in thousands)					(in thousands)
Raw materials	Raw materials	$	71,881	$	68,900	Raw materials	$	73,077	$	67,960
Work in-process	Work in-process	72,969		68,824		Work in-process	78,615		80,720
Finished goods	Finished goods	18,587		16,569		Finished goods	13,254		9,360
		$	163,437	$	154,293		$	164,946	$	158,040

Other current assets:


		September 30, 2021		June 30, 2021			September 30, 2022		June 30, 2022
		(in thousands)					(in thousands)
VAT receivable		$	2,542	$	1,539
Value-added tax receivable						Value-added tax receivable	$	216	$	737
Other prepaid expenses	Other prepaid expenses	2,768		1,465		Other prepaid expenses	4,488		3,954
Prepaid insurance	Prepaid insurance	3,453		2,615		Prepaid insurance	2,997		2,590
Prepaid maintenance	Prepaid maintenance	2,251		1,670		Prepaid maintenance	1,223		826
Prepayment to supplier	Prepayment to supplier	1,434		2,540		Prepayment to supplier	92		257
Prepaid income tax	Prepaid income tax	2,233		2,221		Prepaid income tax	1,149		2,086
Interest receivable	Interest receivable	2,206		2,207		Interest receivable	148		25
Customs deposit		561		270

Other receivables	Other receivables	70		68		Other receivables	717		745

		$	17,518	$	14,595		$	11,030	$	11,220

1215

ALPHA AND OMEGA SEMICONDUCTOR LIMITED

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(Unaudited)

Property, plant and equipment, net:


		September 30, 2021		June 30, 2021			September 30, 2022		June 30, 2022
		(in thousands)					(in thousands)
Land	Land	$	4,877	$	4,877	Land	$	4,877	$	4,877

Building	Building	71,576		71,454		Building	16,930		16,691
Manufacturing machinery and equipment	Manufacturing machinery and equipment	519,732		515,320		Manufacturing machinery and equipment	298,374		287,574
Equipment and tooling	Equipment and tooling	27,500		27,017		Equipment and tooling	29,123		28,052
Computer equipment and software	Computer equipment and software	41,949		41,518		Computer equipment and software	48,053		46,758
Office furniture and equipment	Office furniture and equipment	3,941		3,814		Office furniture and equipment	2,928		2,820
Leasehold improvements	Leasehold improvements	75,178		74,733		Leasehold improvements	36,381		35,254
Land use rights		9,317		9,319

		754,070		748,052			436,666		422,026
Less: accumulated depreciation	Less: accumulated depreciation	(360,510)		(348,749)		Less: accumulated depreciation	(241,857)		(233,340)
		393,560		399,303			194,809		188,686
Equipment and construction in progress	Equipment and construction in progress	47,719		37,674		Equipment and construction in progress	144,661		129,980
Property, plant and equipment, net	Property, plant and equipment, net	$	441,279	$	436,977	Property, plant and equipment, net	$	339,470	$	318,666

Intangible assets, net:


		September 30, 2021		June 30, 2021			September 30, 2022		June 30, 2022
		(in thousands)					(in thousands)
Patents and technology rights	Patents and technology rights	$	18,037	$	18,037	Patents and technology rights	$	18,037	$	18,037
Trade name	Trade name	268		268		Trade name	268		268
Customer relationships	Customer relationships	1,150		1,150		Customer relationships	1,150		1,150
		19,455		19,455			19,455		19,455
Less: accumulated amortization	Less: accumulated amortization	(7,154)		(6,314)		Less: accumulated amortization	(10,513)		(9,674)
		12,301		13,141			8,942		9,781
Goodwill	Goodwill	269		269		Goodwill	269		269
Intangible assets, net	Intangible assets, net	$	12,570	$	13,410	Intangible assets, net	$	9,211	$	10,050

Estimated future minimum amortization expense of intangible assets is as follows (in thousands):


Year ending June 30,	Year ending June 30,			Year ending June 30,
2022 (Remaining)		$	2,520
2023		3,286
2023 (Remaining)				2023 (Remaining)	$	2,446
2024	2024	3,249		2024	3,249
2025	2025	3,246		2025	3,247

		$	12,301
					$	8,942

1316

ALPHA AND OMEGA SEMICONDUCTOR LIMITED

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(Unaudited)

Other long-term assets:


		September 30, 2021		June 30, 2021			September 30, 2022		June 30, 2022
		(in thousands)					(in thousands)
Prepayments for property and equipment	Prepayments for property and equipment	$	20,099	$	14,882	Prepayments for property and equipment	$	2,656	$	6,890
Investment in a privately held company	Investment in a privately held company	100		100		Investment in a privately held company	100		100

Customs deposit	Customs deposit	1,146		1,120		Customs deposit	1,767		1,708
Deposit with supplier						Deposit with supplier	6,297		6,396
Other long-term deposits	Other long-term deposits	926		927		Other long-term deposits	45		18
Office leases deposits	Office leases deposits	1,022		1,100		Office leases deposits	958		1,012
Other	Other	648		740		Other	2,074		1,553
		$	23,941	$	18,869		$	13,897	$	17,677

Accrued liabilities:


		September 30, 2021		June 30, 2021			September 30, 2022		June 30, 2022
		(in thousands)					(in thousands)
Accrued compensation and benefits	Accrued compensation and benefits	$	43,775	$	32,756	Accrued compensation and benefits	$	39,513	$	34,681

Warranty accrual	Warranty accrual	2,824		2,795		Warranty accrual	2,828		2,650
Stock rotation accrual	Stock rotation accrual	3,782		3,917		Stock rotation accrual	4,710		4,798
Accrued professional fees	Accrued professional fees	3,467		3,017		Accrued professional fees	3,346		2,659

Accrued inventory	Accrued inventory	1,204		1,138		Accrued inventory	1,568		2,491
Accrued facilities related expenses	Accrued facilities related expenses	2,751		2,536		Accrued facilities related expenses	3,207		2,421

Accrued property, plant and equipment	Accrued property, plant and equipment	8,473		8,688		Accrued property, plant and equipment	8,634		20,485
Other accrued expenses	Other accrued expenses	6,524		6,793		Other accrued expenses	5,291		5,159
Customer deposit	Customer deposit	17,137		7,139		Customer deposit	36,184		40,578
ESPP payable	ESPP payable	2,270		715		ESPP payable	3,069		971
		$	92,207	$	69,494		$	108,350	$	116,893

The activities in the warranty accrual, included in accrued liabilities, are as follows:
Three Months Ended September 30,
2021 2020
(in thousands)
Beginning balance $ 2,795 $ 709
Additions 139 71
Utilization (110) (73)
Ending balance $ 2,824 $ 707

~~The activities in the stock rotation accrual, included in accrued liabilities, are as follows:~~


		Three Months Ended September 30,					Three Months Ended September 30,
		2021		2020			2022		2021
		(in thousands)					(in thousands)
Beginning balance	Beginning balance	$	3,917	$	3,358	Beginning balance	$	2,650	$	2,795
Additions	Additions	701		3,016		Additions	205		139

Utilization	Utilization	(836)		(2,631)		Utilization	(27)		(110)
Ending balance	Ending balance	$	3,782	$	3,743	Ending balance	$	2,828	$	2,824

1417

ALPHA AND OMEGA SEMICONDUCTOR LIMITED

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(Unaudited)

The activities in the stock rotation accrual, included in accrued liabilities, are as follows:


	Three Months Ended September 30,
	2022		2021
	(in thousands)
Beginning balance	$	4,798	$	3,917
Additions	3,677		701
Utilization	(3,765)		(836)
Ending balance	$	4,710	$	3,782

Other long-term liabilities:


		September 30, 2021		June 30, 2021			September 30, 2022		June 30, 2022
		(in thousands)					(in thousands)
Deferred payroll taxes		$	1,219	$	1,219

Customer deposits	Customer deposits	72,592		42,000		Customer deposits	$	71,701	$	70,301
Other		454		904
Computer software liabilities						Computer software liabilities	7,600		8,302

Other long-term liabilities	Other long-term liabilities	$	74,265	$	44,123	Other long-term liabilities	$	79,301	$	78,603

Customer deposits are payments received from customers for securing future product shipments. As of September 30, ~~2021, $57.0~~2022, $29.5 million were from Customer A and $20.9 million were from Customer B, and ~~$15.6~~$21.3 million were from other customers. As of June 30, ~~2021, $42.0~~2022, $34.5 million were from Customer A and $21.9 million were from Customer B.B, and 13.9 million were from other customers.

1518

ALPHA AND OMEGA SEMICONDUCTOR LIMITED

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(Unaudited)

5.7. Bank Borrowings

Short-term borrowings

On June 29, 2021, the JV Company entered into a one-year loan agreement with China CITIC Bank in China to borrow a maximum of $7.7 million. Interest payments are due on the 20th of each quarter commencing on September 20, 2021, and the entire principal is due on June 29, 2022. As of September 30, 2021, the outstanding balance of this loan was $7.7 million at an interest rate of 3.49% per annum.

On April 19, 2021, the JV Company entered into a loan agreement with China Everbright Bank in China to borrow a maximum of Chinese Renminbi (“RMB” 100 million. The borrowing can be in RMB or U.S. Dollar (“USD”). The loan consists of RMB 50 million for working capital borrowings in Chinese yuan and RMB 50 million for borrowing in USD. The loan is collateralized by eligible accounts receivable. On April 19, 2021, the JV Company borrowed RMB 50.0 million, or $7.7 million based on the currency exchange rate between RMB and USD on April 19, 2021, at an interest rate of 5.1% per annum. The interest payments are due quarterly with the entire principal due no later than May 19, 2022. On June 16, 2021 and June 24, 2021, the JV Company borrowed $4.2 million and $3.5 million at interest rate of 2.7% per annum, and repaid in full during the quarter ended September 30, 2021. On August 17, 2021 and September 22, 2021, the JV Company also borrowed $4.2 million and $3.4 million at interest rate of 2.7% per annum, with principal due on November 9, 2021 and December 12, 2021, respectively. As of September 30, 2021, the total outstanding balance of these loans was $15.3 million.

On November 13, 2020, the JV Company entered into a one-year loan agreement with China Merchant Bank in China. The JV Company can borrow up to RMB 50.0 million, or $7.6 million, based on the currency exchange rate between RMB and U.S. Dollar on November 13, 2020. The loan's interest rates are based on the China one-year loan prime rate (“LPR”) plus 1.4% per annum. Interest payments are due quarterly with the entire principal due not later than November 19, 2021. During the ~~three months ended December 31, 2020,~~ ~~the JV Company borrowed RMB~~ ~~50.0 million, or $7.6 million, at an interest rate of 5.25% per annum. As of September 30, 2021, the outstanding balance of this loan was $7.7 million~~.

OnIn October 2019, the Company's subsidiary in China entered into a line of credit facility with Bank of Communications Limited in China. This line of credit ~~matures~~matured on February 14, 2021 and iswas based on the China Base Rate multiplied by 1.05, or 4.99% on October 31, 2019. The purpose of the credit facility is to provide short-term borrowings. The Company could borrow up to approximately RMB 60.0 million or $8.5 million based on the currency exchange rate between the RMB and the U.S. Dollar on October 31, 2019. In September 2021, this line of credit was renewed with maximum borrowings up to RMB 140.0 million with the same terms and a credit maturity date of September 18, 2022. During the three months ended December 31, 2021, the Company borrowed RMB 11.0 million, or $1.6 million, at an interest rate of 3.85% per annum, with principal due on November 18, 2022. As of September 30, ~~2021, there was~~ no 2022, the total outstanding balance ~~under the loan.~~of this loan was $1.5 million.

On November 16, 2018, one of the Company's ~~subsidiary~~subsidiaries in China entered into a line of credit facility with Industrial and Commercial Bank of China. The purpose of the credit facility was to provide short-term borrowings. The Company could borrow up to approximately RMB 72.0 million or $10.3 million based on currency exchange rate between RMB and U.S. Dollar on November 16, 2018. The RMB 72.0 million consists of RMB 27.0 million for trade borrowings with a maturity date of December 31, 2021, and RMB 45.0 million for working capital borrowings or trade borrowings with a maturity date of September 13, 2022. During the three months ended December 31, 2021, the Company borrowed RMB 5.0 million, or $0.8 million, at an interest rate of 3.7% per annum, with principal due on September 12, 2022. As of September 30, ~~2021,~~2022, there was no ~~was~~ outstandin0 ~~outstanding balance under the loan.~~

g balance.

Accounts Receivable Factoring Agreement

On August 9, 2019, one of the Company's wholly-owned subsidiaries (the “Borrower”) entered into a factoring agreement with the Hongkong and Shanghai Banking Corporation Limited (“HSBC”), whereby the Borrower assigns certain of its accounts receivable with recourse. This factoring agreement allows the Borrower to borrow up to 70% of the net amount of its eligible accounts receivable of the Borrower with a maximum amount of $30.0 million. The interest rate is based on one month London Interbank Offered Rate (“LIBOR”) plus 1.75% per annum. The Company is the guarantor for this agreement. The Company is accounting for this transaction as a secured borrowing under the Transfers and Servicing of Financial Assets guidance. In addition, any cash held in the restricted bank account controlled by HSBC has a legal right of offset against the borrowing. This agreement, with certain financial covenants required, has no expiration date. On August 11, 2021, the Borrower signed an agreement with HSBC to decrease the borrowing maximum amount to $8.0 million with certain financial covenants required. Other terms remain the same. As of September 30, ~~2021,~~2022, the Borrower was in compliance with these covenants. As of September 30, ~~2021,~~ 2022, there was no outstanding balance and the Company had unused credit of ~~approximately~~approximately $8.0 million.

~~Credit Facilities~~

~~ALPHA AND OMEGA SEMICONDUCTOR LIMITED~~

~~NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS~~

~~(Unaudited)~~

Debt financing

~~On May 9, 2018 (the “Effective Date”~~In September 2021, Jireh Semiconductor Incorporated (“Jireh”), one of the ~~JV Company~~wholly-owned subsidiaries, entered into a financing arrangement agreement with a company (“Lender”) for the lease ~~finance~~and purchase of a machinery equipment manufactured by a supplier. This agreement ~~and~~has a ~~security agreement (the “Agreements”) with YinHai Leasing Company and China Import/Export Bank (the “Lenders”). Pursuant~~5 years term, after which Jireh has the option to purchase the ~~Agreements, the Lenders agreed to provide an aggregate of RMB 400.0 million, or $62.8 million~~equipment for $1. The implied interest rate was 4.75% per annum which was adjustable based on every five basis point increase in 60-month U.S. Treasury Notes, until the ~~currency exchange rate between RMB~~final installation and ~~U.S. Dollar on~~acceptance of the ~~Effective Date,~~machine. The total purchase price of ~~financing to~~this machinery equipment was euro 12.0 million. In April 2021, Jireh made a down payment of euro 6.0 million, representing 50% of the ~~JV Company (the “Lease Financing”). In exchange for~~total purchase price of the ~~Lease Financing, the JV Company agreed to transfer title of its assembly and testing~~ equipment, to the ~~Lenders, and~~supplier. In June 2022, the ~~Lenders leased such~~ equipment was delivered to Jireh after Lender paid 40% of the total purchase price, for euro 4.8 million, to the ~~JV Company under a five-year lease arrangement, pursuant~~supplier on behalf of Jireh. In September 2022, Lender paid the remaining 10% payment for the total purchase price and reimbursed Jireh for the 50% down payment, after the installation and configuration of the equipment. The title of the equipment was transferred to ~~which the JV Company makes quarterly lease payments to the Lenders consisting~~Lender following such payment. The agreement was amended with fixed implied interest rate of 7.51% and monthly payment of principal and interest ~~based on a repayment schedule mutually agreed by~~effective in October 2022. Other terms remain the ~~parties.~~same. In addition, Jireh purchased hardware for the machine under this financing arrangement. The ~~interest under the Lease Financing~~purchase price of this hardware was $0.2 million. The financing arrangement is accrued based on the China Base Rate multiplied by 1.15, or 5.4625% on the Effective Date. Under the Agreements, at the end of the five-year lease term, the Lenders agree to sell such equipment back to the JV Company for a nominal amount (RMB 1). The JV Company’s obligations under the Lease Financing are secured by ~~the land and building owned by the JV Company (the “Collateral”). The proceeds from the Lease Financing were used primarily for the acquisition and installation of the 12-inch fabrication~~this machinery equipment and ~~other expenses~~the hardware which had the carrying amount of ~~the JV Company relating to the completion~~$13.1 million as of the fabrication facility located in Chongqing. The Agreements contain customary representation, warranties and covenants, including restrictions on the transfer of the Collateral. The Agreements also contain customary events of default, including but not limited to, failure to make payments and breach of material terms under the Agreements. The Agreements include certain customary closing conditions, including the payment of deposit by the JV Company. On June 28, 2020, the parties entered into a modification to this agreement, pursuant to which the interest rate was changed to be the five-year loan prime rate in China plus 0.8125%, or 5.4625%. Other terms of this agreement remain the same.September 30, 2022. As of September 30, ~~2021,~~2022, the outstanding balance of ~~the Lease Financing of~~ ~~163.0 million RMB (equivalent of~~ ~~$25.2 million~~ ~~based on the currency exchange rate as of September 30, 2021)~~this debt financing was ~~recorded under short-term and long-term finance lease liabilities on balance sheets and summarized in the future minimum lease payment table for finance lease liabilities in Note 6.~~$13.4 million.

Long-term ~~debt~~bank borrowings

ALPHA AND OMEGA SEMICONDUCTOR LIMITED

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(Unaudited)

under the loan agreement is secured by substantially all assets of Jireh and guaranteed by the Company. The agreement has a 5.5 year term and matures on February 16, 2027. Jireh is required to make consecutive quarterly payments of principal and interest. The loan accrues interest based on adjusted LIBOR plus the applicable margin based on the outstanding balance of the loan. This agreement contains customary restrictive covenants and includes certain financial covenants that ~~require~~ the Company is required to maintain. Jireh drew down $45.0 million on February 16, 2022 with the first payment of principal beginning in October 2022. As of September 30, ~~2021, there~~2022, Jireh was in compliance with these covenants and ~~was no outstanding balance under the loan.~~

On April 26, 2020, the JV Company entered into a loan agreement with China Development Bank, Agricultural Bank of China, China Merchants Bank and Chongqing Rural Commercial Bank (collectively, the “Banks”) in the aggregate principal amount of RMB 250 million (approximately $35.7 million based on the currency exchange rate between RMB and U.S. Dollar on April 26, 2020). The obligation under the loan agreement is secured by certain assets of the JV Company. The obligation under the loan agreement is secured by certain assets of the JV Company with a carrying value of $111.7 million as of September 30, 2021. The JV Company is required to make consecutive semi-annual payments of principal until December 8, 2024. Interest payments are due on March 20, June 20, September 20 and December 20 of each year based o~~n the LPR plus 1.3%. The JV Company drew down RMB 250.0 million (approximately $35.3 million based on the currency exchange rate~~ ~~between RMB and U.S. Dollar on June 30, 2020) in April 2020. As of September 30, 2021,~~ the outstanding balance of ~~the loan~~ ~~was $34.1 million.~~

In December 2019, the JV Company entered into a loan agreement with China Development Bank in the amount of $24.0 million. The obligation under the loan agreement is secured by certain assets of the JV Company with a carrying value of $111.7 million as of September 30, 2021. The JV Company is required to make consecutive semi-annual payments of principal until December 8, 2024. The interest is accrued based on the LIBOR rate plus 2.8%. The interest is required to be paid on March 21 and September 21 each year. As of September 30, 2021, the outstanding balance of the loan was~~$19.2 million~~.

~~ALPHA AND OMEGA SEMICONDUCTOR LIMITED~~

~~NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS~~

~~(Unaudited)~~

~~million) of cash is held as restricted cash by the JV Company as a compensating balance at the bank until the principal is paid. On June 24, 2020, a modification of~~ this loan was signed, pursuant to which the interest rate was changed to be based on the five-year loan prime rate in China plus 0.74%, or 5.39%. Other terms of this loan remain the same. As of September 30, 2021, the outstanding balance of the loan was 184.0 million R~~MB (equivalent of~~ $~~28.5 million based on the currency exchange rate as of September 30, 2021).~~45.0 million.

On May 1, 2018, Jireh entered into a loan agreement with the Bank that provided a term loan in the amount of $17.8 million. The obligation under the loan agreement is secured by certain real estate assets of Jireh and guaranteed by the Company. The loan has a five-year term and matures on June 1, 2023. Beginning June 1, 2018, Jireh made consecutive monthly payments of principal and interest to the Bank. The outstanding principal accrues interest at a fixed rate of 5.04% per annum on the basis of a 360-day year. The loan agreement contains customary restrictive covenants and includes certain financial covenants that require the Company to maintain, on a consolidated basis, specified financial ratios. In August 2021, Jireh signed an amendment of this loan with the Bank to modify the financial covenants requirement to align with the new term loan agreement entered into on August 18, 2021 discussed above. The amendment was accounted for as a debt modification and no gain or loss was recognized. The Company was in compliance with these covenants as of September 30, ~~2021.~~2022. As of September 30, ~~2021,~~2022, the outstanding balance of the term loan was ~~$14.8~~$13.9 million.

On August 15, 2017, Jireh entered into a credit agreement with the Bank that provided a term loan in an amount up to $30.0 million for the purpose of purchasing certain equipment for the Company’s fabrication facility located in Oregon. The obligation under the credit agreement is secured by substantially all assets of Jireh and guaranteed by the Company. The credit agreement has a five-year term and ~~matures~~matured on August 15, 2022. In January 2018 and July 2018, Jireh drew down the loan in the amount of $13.2 million and $16.7 million, respectively. Beginning in October 2018, Jireh is required to pay to the Bank on each payment date, the outstanding principal amount of the loan in monthly installments. The loan accrues interest based on an adjusted LIBOR as defined in the credit agreement, plus a specified applicable margin in the range of 1.75% to 2.25%, based on the outstanding balance of the loan. The credit agreement contains customary restrictive covenants and includes certain financial covenants that require the Company to maintain, on a consolidated basis, specified financial ratios and fixed charge coverage ratio. In August 2021, Jireh signed an amendment of this loan with the Bank to modify the financial covenants requirement to align with the new term loan agreement entered into on August 18, 2021, discussed above. The amendment was accounted for as a debt modification and no gain or loss was recognized. The Company was in compliance with these covenants as of September 30, ~~2021.~~2022. As of September 30, ~~2021, the~~2022, there was no outstanding balance ~~of the term loan~~ ~~was~~ ~~$7.5 million.~~.

Maturities of short-term debt and long-term debt were as follows (in thousands):


Year ending June 30,	Year ending June 30,							Year ending June 30,
2022 (Remaining)						$	56,278
2023						38,440
2023 (Remaining)								2023 (Remaining)					$	23,954
2024	2024					24,335		2024					11,472
2025	2025					15,715		2025					11,664

2026								2026					11,871
2027								2027					14,344
Thereafter								Thereafter					536
Total principal	Total principal					134,768		Total principal					73,841
Less: debt issuance costs	Less: debt issuance costs					(822)		Less: debt issuance costs					(150)
Total principal, less debt issuance costs	Total principal, less debt issuance costs					$	133,946	Total principal, less debt issuance costs					$	73,691

		Short-term Debt		Long-term Debt		Total			Short-term Debt		Long-term Debt		Total
Principal amount	Principal amount	$	58,359	$	76,409	$	134,768	Principal amount	$	26,805	$	47,036	$	73,841
Less: debt issuance costs	Less: debt issuance costs	(404)		(418)		(822)		Less: debt issuance costs	(67)		(83)		(150)
Total debt, less debt issuance costs	Total debt, less debt issuance costs	$	57,955	$	75,991	$	133,946	Total debt, less debt issuance costs	$	26,738	$	46,953	$	73,691

1820

ALPHA AND OMEGA SEMICONDUCTOR LIMITED

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(Unaudited)

6.8. Leases

The Company evaluates contracts for lease accounting at contract inception and assesses lease classification at the lease commencement date. Operating leases are included in operating lease right-of-use (“ROU”) assets, operating lease liabilities and operating lease liabilities - long-term on the Company's ~~condensed consolidated balance sheets.~~Condensed Consolidated Balance Sheets. Finance leases are included in property, plant and equipment, finance lease liabilities and finance lease liabilities-long-term on the ~~condensed consolidated balance sheets.~~Condensed Consolidated Balance Sheets. The Company recognizes a ROU asset and corresponding lease obligation liability at the lease commencement date where the lease obligation liability is measured at the present value of the minimum lease payments. As most of the leases do not provide an implicit rate, the Company uses its incremental borrowing rate at lease commencement. The Company uses an interest rate commensurate with the interest rate to borrow on a collateralized basis over a similar term with an amount equal to the lease payments. Operating leases are primarily related to offices, research and development facilities, sales and marketing facilities, and manufacturing facilities. In addition, long-term supply agreements to lease gas tank equipment and purchase industrial gases are accounted for as operating leases. Lease agreements frequently include renewal provisions and require the Company to pay real estate taxes, insurance and maintenance costs. For operating leases, the amortization of the ROU asset and the accretion of its lease obligation liability result in a single straight-line expense recognized over the lease term. The finance lease is related to the $5.1 million of a machinery lease financing with a vendor. In September 2022, the lease was amended to make a monthly payment of principal and interest as a fixed amount effective in October 2022. Other terms remain the same. The amendment was accounted for as a debt modification and no gain or loss was recognized. In addition, the finance lease related to the RMB 400.0 million of lease financing of the JV Company with YinHai Leasing Company and The Export-Import Bank of ~~China. See Note 5 - Bank Borrowings for details.~~China was not included in the Company’s unaudited Condensed Consolidated Balance Sheet at September 30, 2022 due to the deconsolidation of the JV Company on December 2, 2021. The Company does not record leases on the ~~condensed consolidated balance sheets~~Condensed Consolidated Balance Sheets with a term of one year or less.

The Company’s unaudited Condensed Consolidated Statements of Income for the three months ended September 30, 2021 include the JV Company's results for the period preceding the deconsolidation on December 2, 2021. The components of the Company’s operating and finance lease expenses are as follows for the periods presented (in thousands):


		Three Months Ended September 30,					Three Months Ended September 30,
		2021		2020			2022		2021
Operating leases:	Operating leases:					Operating leases:
Fixed rent expense	Fixed rent expense	$	1,801	$	1,688	Fixed rent expense	$	1,413	$	1,801
Variable rent expense	Variable rent expense	298		203		Variable rent expense	237		298
Finance lease:	Finance lease:					Finance lease:
Amortization of equipment	Amortization of equipment	468		559		Amortization of equipment	137		468
Interest	Interest	410		615		Interest	57		410
Short-term leases	Short-term leases					Short-term leases
Short-term lease expenses	Short-term lease expenses	54		58		Short-term lease expenses	80		54
Total lease expenses	Total lease expenses	$	3,031	$	3,123	Total lease expenses	$	1,924	$	3,031

1921

ALPHA AND OMEGA SEMICONDUCTOR LIMITED

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(Unaudited)

Supplemental balance sheets information related to the Company’s operating and finance leases is as follows (in thousands, except lease term and discount rate):


		September 30, 2021			June 30, 2021				September 30, 2022			June 30, 2022
Operating Leases:	Operating Leases:							Operating Leases:
ROU assets associated with operating leases	ROU assets associated with operating leases	$	33,437		$	34,660		ROU assets associated with operating leases	$	24,251		$	23,674
Finance Lease:	Finance Lease:							Finance Lease:
Property, plant and equipment, gross	Property, plant and equipment, gross	$	114,389		$	114,404		Property, plant and equipment, gross	$	5,133		$	4,831
Accumulated depreciation	Accumulated depreciation	(96,809)			(96,470)			Accumulated depreciation	(272)			(136)
Property, plant and equipment, net	Property, plant and equipment, net	$	17,580		$	17,934		Property, plant and equipment, net	$	4,861		$	4,695

Weighted average remaining lease term (in years)	Weighted average remaining lease term (in years)							Weighted average remaining lease term (in years)
Operating leases	Operating leases	8.30			8.44			Operating leases	6.99			7.42
Finance lease	Finance lease	1.47			1.72			Finance lease	5.00			5.00

Weighted average discount rate	Weighted average discount rate							Weighted average discount rate
Operating leases	Operating leases	4.68		%	4.67		%	Operating leases	4.31		%	4.27		%
Finance lease	Finance lease	5.46		%	5.46		%	Finance lease	7.51		%	4.76		%

Supplemental cash flow information related to the Company’s operating and finance lease is as follows (in thousands):


		Three Months Ended September 30,					Three Months Ended September 30,
		2021		2020			2022		2021
Cash paid from amounts included in the measurement of lease liabilities:	Cash paid from amounts included in the measurement of lease liabilities:					Cash paid from amounts included in the measurement of lease liabilities:
Operating cash flows from operating leases	Operating cash flows from operating leases	$	1,811	$	1,642	Operating cash flows from operating leases	$	1,487	$	1,811
Operating cash flows from finance lease	Operating cash flows from finance lease	$	410	$	615	Operating cash flows from finance lease	$	57	$	410
Financing cash flows from finance lease	Financing cash flows from finance lease	$	4,176	$	3,989	Financing cash flows from finance lease	$	201	$	4,176

Non-cash investing and financing information:	Non-cash investing and financing information:					Non-cash investing and financing information:
Operating lease right-of-use assets obtained in exchange for lease obligations	Operating lease right-of-use assets obtained in exchange for lease obligations	$	164	$	137	Operating lease right-of-use assets obtained in exchange for lease obligations	$	1,924	$	164

Future minimum lease payments are as follows as of September 30, ~~2021~~2022 (in thousands):

Year ending June 30, Operating Leases Finance Leases
The remainder of fiscal 2022 $ 5,481 $ 13,413
2023 6,132 13,050
2024 4,729 —
2025 3,765 —
2026 3,743 —
Thereafter 18,849 —
Total minimum lease payments 42,699 26,463
Less amount representing interest (7,820) (1,225)
Total lease liabilities $ 34,879 $ 25,238


Year ending June 30,	Operating Leases		Finance Leases
The remainder of fiscal 2023	$	4,223	$	859
2024	4,621		1,144
2025	3,794		1,144
2026	3,179		1,144
2027	3,104		1,144
Thereafter	10,139		192
Total minimum lease payments	29,060		5,627
Less amount representing interest	(4,193)		(934)
Total lease liabilities	$	24,867	$	4,693

2022

ALPHA AND OMEGA SEMICONDUCTOR LIMITED

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(Unaudited)

7.9. Shareholders' Equity and Share-based Compensation

Share Repurchase

In September 2017, the Board of Directors approved a repurchase program (the “Repurchase Program”) that allowed the Company to repurchase its common shares from the open market pursuant to a pre-established Rule 10b5-1 trading plan or through privately negotiated transactions up to an aggregate of $30.0 million. The amount and timing of any repurchases under the Repurchase Program depend on a number of factors, including but not limited to, the trading price, volume and availability of the Company’s common shares. Shares repurchased under this program are accounted for as treasury shares and the total cost of shares repurchased is recorded as a reduction of shareholders' equity. From time to time, treasury shares may be reissued as part of the Company’s share-based compensation programs. Gains on re-issuance of treasury stock are credited to additional paid-in capital; losses are charged to additional paid-in capital to offset the net gains, if any, from previous sales or re-issuance of treasury stock. Any remaining balance of the losses is charged to retained earnings.

During the three months ended September 30, ~~2021,~~2022, the Company did not repurchase any shares pursuant to the Repurchase Program. Since the inception of the program, the Company repurchased an aggregate of 6,784,648 shares for a total cost of $67.3 million, at an average price of $9.92 per share, excluding fees and related expenses. No repurchased shares have been retired. Of the 6,784,648 repurchased shares, ~~161,145~~ 167,895 shares with a weighted average repurchase price of ~~$10.13~~$10.06 per share, were reissued at an average price of ~~$5.19~~$4.98 per share pursuant to option exercises and vested restricted share units (“RSU”). As of September 30, ~~2021,~~2022, approximately $13.4 million remained available under the Re~~purchase~~Repurchase Program.

Time-based Restricted Stock Units (“TRSU”)

The following table summarizes the Company's TRSU activities for the three months ended September 30, ~~2021:~~2022:


		Number of Restricted Stock Units	Weighted Average Grant Date Fair Value Per Share		Weighted Average Remaining Contractual Term (Years)	Aggregate Intrinsic Value			Number of Restricted Stock Units	Weighted Average Grant Date Fair Value Per Share		Weighted Average Remaining Contractual Term (Years)	Aggregate Intrinsic Value
Nonvested at June 30, 2021		1,053,524	$	21.60	1.73	$	32,016,594
Nonvested at June 30, 2022								Nonvested at June 30, 2022	1,169,609	$	34.03	1.73	$	38,994,764
Granted	Granted	52,500	$	27.38				Granted	90,500	$	37.14
Vested	Vested	(28,853)	$	16.48				Vested	(36,516)	$	25.44
Forfeited	Forfeited	(25,125)	$	22.29				Forfeited	(20,275)	$	33.23
Nonvested at September 30, 2021		1,052,046	$	22.01	1.56	$	33,002,683
Nonvested at September 30, 2022								Nonvested at September 30, 2022	1,203,318	$	34.54	1.59	$	37,014,062

Market-based Restricted Stock Units (“MSU”)

In December 2021, the Company granted 1.0 million market-based restricted stock units ("MSUs") to its certain personnel. The number of shares to be earned at the end of performance period is determined based on the Company’s achievement of specified stock prices and revenue thresholds during the performance period from January 1, 2022 to December 31, 2024 as well as the recipients remaining in continuous service with the Company through such period. The MSU vests in four equal annual installments after the end of performance period. The Company estimated the grant date fair values of its MSU with derived service periods of 4.1 to 7.1 years using a Monte-Carlo simulation model with the following assumptions: Risk-free interest rate of 1.0%, expected term of 3.1 years, expected volatility of 62.8% and dividend yield of 0%. The Company recorded approximately $2.0 million and nil of expenses for these MSUs during the three months ended September 30, 2022 and 2021, respectively.

During the quarter ended September 30, 2018, the Company granted 1.3 million MSUs to certain personnel. The number of shares to be earned at the end of performance period is determined based on the Company’s achievement of specified stock prices and revenue thresholds during the performance period from January 1, 2019 to December 31, 2021 as well as the recipients remaining in continuous service with the Company through such period. The MSUs vest in four equal annual installments after the end of the performance period. The Company estimated the grant date fair values of its MSUs using a Monte-Carlo simulation model. On August 31, 2020, the Compensation Committee of the Board approved a modification of the terms of MSU to (i) extend the performance period through December 31, 2022 and (ii) change the commencement date for the four-year time-based service period to January 1, 2023. The fair value of these MSUs was recalculated to reflect the change as of August 31, 2020 and the unrecognized compensation amount was adjusted to reflect the increase in fair value. The Company recorded approximately~~$0.4 million~~ $0.6 million and ~~$0.2~~ $0.4 million of expenses for MSUs during the three months ended September 30, 2022 and 2021, ~~and 2020,~~ respectively.

ALPHA AND OMEGA SEMICONDUCTOR LIMITED

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(Unaudited)

Performance-based Restricted Stock Units (“PRSUs”)

In March each year since year 2017, the Company granted PRSUs to certain personnel. The number of shares to be earned under the PRSUs is determined based on the level of attainment of predetermined financial goals. The PRSUs vest in four equal annual installments from the first anniversary date after the grant date if certain predetermined financial goals were met. The Company recorded ~~approximatel~~y ~~$1.0~~approximately $1.6 million and ~~$0.4~~$1.0 million of expense for these PRSUs during the three months ended September 30, 2022 and 2021, ~~and 2020,~~ respectively.

~~ALPHA AND OMEGA SEMICONDUCTOR LIMITED~~

~~NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS~~

~~(Unaudited)~~

During the three months ended June 30, 2019, the Company announced an incentive program. Under this program, each participant’s award is denominated in stock and subject to achievement of certain objective goals within certain timelines. In June 2020, the Company believed it was most likely that predetermined goal measures would be met. Therefore, the Company reported such expenses in the other current liabilities line on the condensed consolidated balance sheets as the amount of bonus is to be settled in variable number of RSU’s at the completion of the objective goals. Such non-cash compensation expense was recorded as part of share-based compensation exp~~ense in the condensed consolidated statements of operations. As of September 30, 2021 and June 30, 2021, the Company recorded~~ ~~$0.2 million~~ ~~and $0.1 million such expenses in the other current liabilities, respectively. During~~ ~~the three months ended September 30, 2021 and 2020~~, ~~the Company recorded $0.1 million and $0.6 million such non-cash compensation expense, respectively.~~ ~~As of September 30, 2021, the Company granted RSUs valued at~~ ~~$3.6 million to participants, which were fully vested due to achievement of certain objective measures.~~

The following table summarizes the Company’s PRSUs activities for the three months ended September 30, ~~2021:~~2022:

Number of Performance-based Restricted Stock
Units Weighted Average
Grant Date Fair
Value Per Share Weighted Average
Remaining
Contractual Term
(Years) Aggregate Intrinsic Value
Nonvested at June 30, 2021 353,824 $ 22.69 1.74 $ 10,752,711
Forfeited (250) $ 16.22
Nonvested at September 31, 2021 353,574 $ 22.69 1.48 $ 11,091,616


	Number of Performance-based Restricted Stock Units	Weighted Average Grant Date Fair Value Per Share		Weighted Average Remaining Contractual Term (Years)	Aggregate Intrinsic Value
Nonvested at June 30, 2022	389,375	$	36.56	1.85	$	12,981,763



Nonvested at September 30, 2022	389,375	$	36.56	1.59	$	11,977,175

Stock Options

The Company did not grant any stock options during the three months ended September 30, ~~2021~~2022 and ~~2020.~~2021. The following table summarizes the Company's stock option activities for the three months ended September 30, ~~2021:~~2022:

Weighted
Weighted Average
Average Remaining
Number of Exercise Price Contractual Aggregate
Shares Per Share Term (in years) Intrinsic Value
Outstanding at June 30, 2021 487,875 $ 7.99 2.32 $ 10,928,653
Outstanding at September 30, 2021 487,875 $ 7.99 2.07 $ 11,406,770
Options vested and expected to vest 487,875 $ 7.99 2.07 $ 11,406,770
Exercisable at September 30, 2021 487,875 $ 7.99 2.07 $ 11,406,770


				Weighted
		Weighted		Average
		Average		Remaining
	Number of	Exercise Price		Contractual	Aggregate
	Shares	Per Share		Term (in years)	Intrinsic Value
Outstanding at June 30, 2022	389,875	$	7.70	1.53	$	9,997,364

Exercised	(2,500)	$	7.56		$	87,500

Outstanding at September 30, 2022	387,375	$	7.70	1.28	$	8,933,486
Options vested and expected to vest	387,375	$	7.70	1.28	$	8,933,486
Exercisable at September 30, 2022	387,375	$	7.70	1.28	$	8,933,486

Employee Share Purchase Plan (“ESPP”)

The assumptions used to estimate the fair values of common shares issued under the ESPP were as follows:



			Three Months ~~End~~Ended September 30,
			~~2021~~2022
Volatility rate			~~68.5%~~69.9%
Risk-free interest rate			~~0.1%~~2.1%
Expected term			1.3 years
Dividend yield			0%

2224

ALPHA AND OMEGA SEMICONDUCTOR LIMITED

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(Unaudited)

Share-based Compensation Expense

TheOn September 8, 2022, the Compensation Committee of the Board approved modifications to the terms of equity awards granted to a former officer who is currently a board member of the Company. The modifications waived the four-year time based service performance of his MSU and allowed continuing vesting of his TRSU and PRSU according to the original awards' vesting schedule after his termination as a board member. The incremental expenses for these equity shares resulting from the modification were $3.9 million. During the three months ended September 30, 2022, the Company recorded $0.3 million, net of reversal of prior recorded expenses, of shared-based compensation for these equity shares.

The total share-based compensation expense recognized in the ~~condensed consolidated statements~~Condensed Consolidated Statements of ~~operations~~Income for the periods presented was as follows:


		Three Months Ended September 30,				Three Months Ended September 30,
		2021		2020				2022		2021
		(in thousands)				(in thousands)
Cost of goods sold	Cost of goods sold	$	569	$	385		Cost of goods sold	$	1,788	$	569
Research and development	Research and development	1,043		1,080			Research and development	2,494		1,043
Selling, general and administrative	Selling, general and administrative	3,023		1,411			Selling, general and administrative	6,314		3,023
		$	4,635	$	2,876			$	10,596	$	4,635

As of September 30, ~~2021,~~2022, total unrecognized compensation cost under the Company's equity plans was ~~$24.5~~was $78.7 million, which is expected to be recognized over a weighted-average period of ~~1.9~~2.9 years.

8.10. Income Taxes

The Company recognized income tax expense of approximately ~~$1.3~~$1.4 million and ~~$1.0~~$1.3 million for the three months ended September 30, 2022 and 2021, ~~and 2020,~~ respectively. The income tax expense of $1.4 million for the three months ended September 30, 2022 included a $0.07 million discrete tax expense. The income tax expense of $1.3 million for the three months ended September 30, 2021 included a $0.09 million discrete tax expense. ~~The income tax expense of $1.0 million for the three months ended September 30, 2020 included a $0.03 million discrete tax benefit.~~ Excluding the discrete income tax items, the effective tax rate for the three months ended September 30, 2022 and 2021 was 4.8% and ~~2020 was~~ 5.4% ~~and 10.7%~~, respectively. The changes in the tax expense and effective tax rate ~~and tax expense~~ between the periods resulted primarily from changes in the ~~Company reporting pretax book income~~mix of ~~$22.8 million for~~earnings in various geographic jurisdictions between the ~~three months ended September 30, 2021 as compared to a pretax book income~~current year and the same period of ~~$9.8 million for the three months ended September 30, 2020.~~last year.

The Company files its income tax returns in the United States and in various foreign jurisdictions. The tax years 2001 to ~~2021~~2022 remain open to examination by U.S. federal and state tax authorities. The tax years ~~2013~~2014 to ~~2021~~2022 remain open to examination by foreign tax authorities.

The Company's income tax returns are subject to examinations by the Internal Revenue Service and other tax authorities in various jurisdictions. In accordance with the guidance on the accounting for uncertainty in income taxes, the Company regularly assesses the likelihood of adverse outcomes resulting from these examinations to determine the adequacy of its provision for income taxes. These assessments can require considerable estimates and judgments. As of September 30, ~~2021,~~2022, the gross amount of unrecognized tax benefits was approximately ~~$7.7~~$8.6 million, of which ~~$4.7~~$5.6 million, if recognized, would reduce the effective income tax rate in future periods. If the Company's estimate of income tax liabilities proves to be less than the ultimate assessment, then a further charge to expense would be required. If events occur and the payment of these amounts ultimately proves to be unnecessary, the reversal of the liabilities would result in tax benefits being recognized in the period when the Company determines the liabilities are no longer necessary. The Company does not anticipate any material changes to its uncertain tax positions during the next twelve months.

“~~U.S. Consolidated Appropriations~~The Chip and Science Act ~~2021” (“CAA 2021”)~~of 2022”, Enacted ~~December 27, 2020~~August 2, 2022

OnIn August 2022 the U.S. enacted the Chip and Science Act of 2022 (the Chips Act). The Chips Act provides incentives to semiconductor chip manufacturers in the United States, including providing a 25% manufacturing investment credits for investments in semiconductor manufacturing property placed in service after December ~~27, 2020,~~31, 2022, for which construction begins before January 1, 2027. Property investments qualify for the 25% credit if, among other requirements, the property is integral to the operation of an advanced manufacturing facility, defined as having a primary purpose of manufacturing semiconductors or semiconductor manufacturing equipment. Currently, we are evaluating the impact of the Chips Act to us.

ALPHA AND OMEGA SEMICONDUCTOR LIMITED

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(Unaudited)

“The Inflation Reduction Act”, Enacted August 16, 2022

In August 2022 the United States enacted tax legislation through the ~~Consolidated Appropriations~~Inflation Reduction Act ~~2021, which made changes to existing U.S.~~(IRA). The IRA introduces a 15% corporate alternative minimum tax ~~laws. There was no material impact of~~(CAMT) for corporations whose average annual adjusted financial statement income (AFSI) for any consecutive three-tax-year period preceding the applicable tax ~~law changes included in the Consolidated Appropriations Act, 2021~~year exceeds $1 billion. The CAMT is effective for tax years beginning after December 31, 2022. The CAMT is currently not applicable to the Company.

~~“The American Rescue Plan Act of 2021”, Enacted March 11, 2021~~

On March 11, 2021, the United States enacted the American Rescue Plan Act of 2021, which made changes to existing U.S. tax laws. There was no material impact of the tax law changes included in the American Rescue Plan Act of 2021 to the Company.Altera Litigation

On July 27, 2015, in Altera Corp. v. Commissioner, the U.S. Tax Court issued an opinion related to the treatment of stock-based compensation expense in an intercompany cost-sharing arrangement. In the July 2015 ruling, the Tax Court concluded that the sharing of the cost of employee stock compensation in a company’s cost-sharing arrangement was invalid under the U.S.

~~ALPHA AND OMEGA SEMICONDUCTOR LIMITED~~

~~NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS~~

~~(Unaudited)~~

Administrative Procedures Act. In June 2019, a panel of the Ninth Circuit of the U.S. Court of Appeals reversed this decision. In July 2019, Altera petitioned U.S. Court of Appeals for the Ninth Circuit to hold an en banc rehearing of the case. The petition was subsequently denied by the Ninth Circuit. Altera appealed the case to the U.S. Supreme Court in February 2020, but the U.S. Supreme Court declined to hear the case in June 2020, leaving intact the U.S. Court of Appeals for the Ninth Circuit’s decision. AOS has not recorded any benefit related to the Altera Corporation Tax Court decision in any period through September ~~2021.~~2022. The Company will continue to monitor ongoing developments and potential impact to its financial statements.

2426

ALPHA AND OMEGA SEMICONDUCTOR LIMITED

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(Unaudited)

9.11. Segment and Geographic Information

The Company is organized as, and operates in, 1one operating segment: the design, development and supply of power semiconductor products for computing, consumer electronics, communication and industrial applications. The chief operating decision-maker is the Chief Executive Officer. The financial information presented to the Company’s Chief Executive Officer is on a consolidated basis, accompanied by information about revenue by customer and geographic region, for purposes of evaluating financial performance and allocating resources. The Company has 1one business segment, and there are no segment managers who are held accountable for operations, operating results and plans for products or components below the consolidated unit level. Accordingly, the Company reports as a single operating segment.

The Company sells its products primarily to distributors in the Asia Pacific region, who in turn sell these products to end customers. Because the Company’s distributors sell their products to end customers which may have a global presence, revenue by geographical location is not necessarily representative of the geographical distribution of sales to end user markets.

The revenue by geographical location in the following tables is based on the country or region in which the products were shipped to:

Three Months Ended September 30,
2021 2020
(in thousands)
Hong Kong $ 148,655 $ 125,508
China 32,840 23,263
South Korea 2,854 1,174
United States 2,305 1,456
Other countries 381 150
$ 187,035 $ 151,551

During the three months ended September 30, 2021, the Company corrected an immaterial error to reduce revenues in Hong Kong by $1.1 million, to increase the revenues in China and South Korea by $54,000 and $1.0 million, respectively, for the three months ended September 30, 2020.


	Three Months Ended September 30,
	2022		2021
	(in thousands)
Hong Kong	$	172,296	$	148,655
China	28,014		32,840
South Korea	2,897		2,854
United States	4,484		2,305
Other countries	785		381
	$	208,476	$	187,035

The following is a summary of revenue by product type:


		Three Months Ended September 30,				Three Months Ended September 30,
		2021		2020				2022		2021
		(in thousands)				(in thousands)
Power discrete	Power discrete	$	130,688	$	119,375		Power discrete	$	145,139	$	130,688
Power IC	Power IC	52,330		29,455			Power IC	61,754		52,330
Packaging and testing services	Packaging and testing services	4,017		2,721			Packaging and testing services	1,583		4,017
		$	187,035	$	151,551			$	208,476	$	187,035

Long-lived assets, net consisting of property, plant and equipment and operating lease right-of-use assets, net by geographical area are as follows:


	September 30, 2022		June 30, 2022
	(in thousands)
China	$	111,151	$	105,326
United States	248,679		232,731
Other countries	3,891		4,283
	$	363,721	$	342,340

ALPHA AND OMEGA SEMICONDUCTOR LIMITED

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(Unaudited)

~~Long-lived assets, net consisting of property, plant and equipment and land use rights, net, as well as operating lease right-of-use assets, net by geographical area are as follows:~~

September 30,
2021 June 30,
2021
(in thousands)
China $ 353,844 $ 350,387
United States 118,160 118,756
Other countries 2,712 2,494
$ 474,716 $ 471,637

~~10.~~12. Commitments and Contingencies

Purchase Commitments

As of September 30, ~~2021~~2022 and June 30, ~~2021,~~2022, the Company had approximately ~~$86.7~~$93.6 million and ~~$81.8~~$89.9 million, respectively, of outstanding purchase commitments primarily for purchases of semiconductor raw materials, wafers, spare parts, packaging and testing services and others.

As of September 30, ~~2021~~2022 and June 30, ~~2021,~~2022, the Company had approximately ~~$128.2~~$32.5 million and ~~$90.0~~$63.4 million, ~~primarily for the Jireh and JV Company,~~ respectively, of capital commitments for the purchase of property and ~~equipment.~~equipment.

Other Commitments

See Note ~~1, Note 5~~7 and Note 68 of the Notes to the Condensed Consolidated Financial Statements contained in this Quarterly Report on Form 10-Q for descriptions of commitments including ~~Joint Venture,~~ bank borrowings and leases.

Contingencies and Indemnities

The Company has in the past, and may from time to time in the future, become involved in legal proceedings arising from the normal course of business activities. The semiconductor industry is characterized by frequent claims and litigation, including claims regarding patent and other intellectual property rights as well as improper hiring practices. Irrespective of the validity of such claims, the Company could incur significant costs in the defense of such claims and suffer adverse effects on its operations.

In December 2019, the U.S. Department of Justice (“DOJ”) commenced an investigation into the Company's compliance with export control regulations relating to its business transactions with Huawei and its affiliates (“Huawei”), which were added to the “Entity List” maintained by the Department of Commerce (“DOC”) on May 16, 2019. The Company is cooperating fully with federal authorities in the investigation, including responding to requests for documents, information and interviews from DOJ in connection with the investigation. The Company has maintained an export control compliance program and has been committed to comply fully with all applicable laws and regulations. In connection with this investigation, DOC requested the Company to suspend shipments of its products to Huawei, and the Company complied with such request, and the Company has not shipped any product to Huawei after December 31, 2019. The Company is currently working with DOC to resolve this issue. Given the case is in still ongoing and neither DOJ nor DOC have provided the Company with any clear indication of the timing and schedule for the investigation, the Company cannot estimate the reasonably possible loss or range of loss that may occur. Also, the Company is unable to predict the duration, scope, result or related costs of the investigation, although the Company expects to incur additional professional fees as a result of this matter. In addition, the Company is unable to predict what, if any, further action that may be taken by the government in connection with the investigation, or what, if any, penalties, sanctions or remedial actions may be sought.

On March 19, 2020, Darryl Gray, a stockholder of the Company (the “Plaintiff”), filed a putative class action complaint in the United States District Court for the Southern District of New York (the “Gray Action”), alleging that the Company and its management members made material misstatements or omissions regarding the Company’s business and operations, including its export control practices relating to business transactions with Huawei and its affiliate. The Gray Action asserts claims under Section 10(b) of the Exchange Act against the Company, its Chief Executive Officer and Chief Financial Officer (collectively, the “Defendants”), as well as claims under Section 20(a) of the Exchange Act against the Chief Executive Officer and Chief

~~ALPHA AND OMEGA SEMICONDUCTOR LIMITED~~

~~NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS~~

~~(Unaudited)~~

~~Financial Officer. Among other remedies, the Gray Action seeks to recover compensatory and other damages as well as attorney’s fees and costs.~~

On May 18, 2020, Plaintiff moved for an order appointing him as Lead Plaintiff pursuant to Section 21D of the Exchange Act and approving Glancy Prongay & Murray LLP as Lead Counsel for the putative class (the “Motion”). On July 1, 2020, the Court entered an order granting the Motion and requiring that: (i) Lead Plaintiff file an amended complaint or designate the current complaint as operative within sixty days; (ii) Defendants answer the complaint or otherwise move within sixty days of such filing or designation; (iii) Lead Plaintiff file an opposition, if any, within forty-five days; and (iv) Defendants file a reply, if any, forty-five days thereafter. On August 28, 2020, Plaintiff filed an amended complaint asserting the same claims against the Defendants, and adding the Company’s Executive Vice President of Product Line as a defendant on both claims. On October 27, 2020, the Defendants moved to dismiss the action in its entirety. Plaintiff filed his opposition on December 11, 2020 and Defendants filed their reply brief on January 25, 2021. On September 27, 2021, the Court entered an opinion and order granting Defendants’ motion and dismissing the amended complaint in its entirety. In so doing, the Court found, among other things, that Plaintiff failed adequately to allege that any of AOS’s indirect sales to Huawei were illegal, and therefore none of the Company’s statements regarding its positive performance or its efforts to contend with a difficult geopolitical climate and trade tensions could plausibly be seen as “inaccurate, incomplete, or misleading.” The Court’s order allowed Plaintiff an opportunity to file a second amended complaint by October 27, 2021, attempting to cure the various deficiencies, barring which the matter would be dismissed with prejudice. As of that date, however, no such filing was made and the Company anticipates that the matter will be dismissed with prejudice.

The Company is a party to a variety of agreements that it has contracted with various third parties. Pursuant to these agreements, the Company may be obligated to indemnify another party to such an agreement with respect to certain matters. Typically, these obligations arise in the context of contracts entered into by the Company, under which the Company customarily agrees to hold the other party harmless against losses arising from a breach of representations and covenants related to such matters as title to assets sold, certain intellectual property rights, specified environmental matters and certain income taxes. In these circumstances, payment by the Company is customarily conditioned on the other party making a claim pursuant to the procedures specified in the particular contract, which procedures typically allow the Company to challenge the other party's claim. Further, the Company's obligations under these agreements may be limited in time and/or amount, and in some instances, the Company may have recourse against third parties for certain payments made by it under these agreements. The Company has not historically paid or recorded any material indemnifications, and no accrual was made at September 30, ~~2021~~2022 and June 30, ~~2021.~~2022.

The Company has agreed to indemnify its directors and certain employees as permitted by law and pursuant to its Bye-laws, and has entered into indemnification agreements with its directors and executive officers. The Company has not recorded a liability associated with these indemnification arrangements, as it historically has not incurred any material costs associated with such indemnification obligations. Costs associated with such indemnification obligations may be mitigated by insurance coverage that the Company maintains. However, such insurance may not cover any, or may cover only a portion of, the amounts the Company may be required to pay. In addition, the Company may not be able to ~~acquire,~~ maintain ~~or renew~~ such insurance coverage at reasonable cost, if at all, in the ~~future under favorable terms or at all.~~future.

2728

ITEM 2. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS

Except for the historical information contained herein, the matters addressed in this Item 2 constitute “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. These forward looking statements include, but are not limited to, statements regarding future financial performance of the Company; the expected ramp up timeline of the 12-inch fab at the JV Company; the impact of government investigation and coronavirus on our financial performance; and other statements and information set forth under the heading “Factors Affecting Our Performance”. Such forward-looking statements are subject to a variety of risks and uncertainties, including those discussed below under the heading “Risk Factors” and elsewhere in this Quarterly Report on Form 10-Q, that could cause actual results to differ materially from those anticipated by the Company’s management. The Private Securities Litigation Reform Act of 1995 (the “Act”) provides certain “safe harbor” provisions for forward-looking statements. All forward-looking statements made in this Quarterly Report on Form 10-Q are made pursuant to the Act. The Company undertakes no obligation to publicly release the results of any revisions to its forward-looking statements that may be made to reflect events or circumstances after the date hereof or to reflect the occurrence of unexpected events. Unless the context otherwise requires, the words “AOS,” the “Company,” “we,” “us” and “our” refer to Alpha and Omega Semiconductor Limited and its subsidiaries.

This management’s discussion should be read in conjunction with the management’s discussion included in the Company’s Annual Report on Form 10-K for the fiscal year ended June 30, ~~2021,~~2022, filed with the Securities and Exchange Commission on ~~August 30, 2021.~~September 19, 2022.

Overview

We are a designer, developer and global supplier of a broad portfolio of power semiconductors. Our portfolio of power semiconductors includes approximately ~~2,400~~2,500 products, and has grown significantly with the introduction of over 130 new products in the fiscal year ended June 30, 2022, and over 160 new products in each of the fiscal years ended June 30, 2021 and 2020, ~~respectively, and 200 new products in the fiscal year ended June 30, 2019,~~ respectively. During the three months ended September 30, ~~2021,~~2022, we introduced an additional 1716 new products. Our teams of scientists and engineers have developed extensive intellectual ~~properties~~property and technical knowledge that encompass major aspects of power semiconductors, which we believe enables us to introduce and develop innovative products to address the increasingly complex power requirements of advanced electronics. We have an extensive patent portfolio that consists of ~~870~~894 patents and 5659 patent applications in the United States as of September 30, ~~2021.~~2022. We also have a total of ~~907~~954 foreign patents, which were based primarily on our research and development efforts through September 30, ~~2021.~~2022. We differentiate ourselves by integrating our expertise in technology, design and advanced manufacturing and packaging to optimize product performance and cost. Our portfolio of products targets high-volume applications, including personal ~~and portable~~ computers, graphic cards, game consoles, flat panel TVs, home appliances, power tools, smart phones, battery packs, ~~game consoles,~~ consumer and industrial motor controls and power supplies for TVs, computers, servers and telecommunications equipment.

Our business model leverages global resources, including research and development and manufacturing in the United States and Asia. Our sales and technical support teams are localized in several growing markets. We operate an 8-inch wafer fabrication facility located in Hillsboro, Oregon, or the Oregon ~~fab,~~Fab, which is critical for us to accelerate proprietary technology development, new product introduction and improve our financial performance. To meet the market demand for the more mature high volume products, we also utilize the wafer manufacturing capacity of selected third party foundries. For assembly and test, we primarily rely upon our in-house facilities in China. In addition, we utilize subcontracting partners for industry standard packages. We believe our in-house packaging and testing capability provides us with a competitive advantage in proprietary packaging technology, product quality, cost and sales cycle time.

We operate a power semiconductor packaging, testing and wafer fabrication facility in the Liangjiang New Area of Chongqing, China through our joint venture (the “JV Company”) with two investment funds owned by the Municipality of Chongqing (the “Chongqing Funds”). We currently own 51%, and the Chongqing Funds own 49%, of the equity interest in the JV Company. While the JV Company is our consolidated subsidiary for purpose of financial reporting, it operates as an independent and separate legal entity. As a result, the JV Company’s assets and liabilities are segregated from our company's assets and liabilities. For example, the JV Company incurs debt through its own financing and bank loan agreements, and our parent company and other subsidiaries are not parties to these agreements and do not provide any guarantee or security for the JV Company’s debt, nor do we have direct access to any cash proceeds borrowed from such loan agreements. As part of our strategic plan, we formed the JV Company to fulfill growing customer demand. The JV Company has reached its targeted production of assembly and testing, and has ramped up its Phase I target run rate of the 12-inch wafer fabrication in the quarter ended September 30, 2021. During the three months ended September 30, 2021, we recorded $2.0 million in net loss attributable to the noncontrolling interest in the JV Company. The additional capacity at the JV Company contributed significantly to meeting the increasing demand for our products. However, the financial performance of the JV Company is

affected by various factors, including the impact of the global COVID-19 pandemic and related economic downturn, intensified geopolitical tensions between China and U.S., logistical difficulties, the JV Company’s ability to obtain financing and other risk factors beyond our control. We will continue to monitor and evaluate market conditions closely and react quickly to the changing environment as necessary to achieve an optimal production level at the JV Company. In addition, the JV Company is currently pursuing various financing options to fund its future expansion and repay its debt obligations, and there is no guarantee that the JV Company will be able obtain such financing with favorable terms, or at all. We expect the joint venture to provide important capacity to support our future growth, enhance our market positions in China, and drive improvements in capital expenditures.

During the fiscal quarter ended September 30, ~~2021,~~2022, we continued our product diversification program by developing new silicon and packaging platforms to expand our serviceable available market, or SAM and offer higher performance products. Our metal-oxide-semiconductor field-effect transistors, or MOSFET, and power IC product portfolio expanded significantly. Our high performance products and deepened customer relationships with our OEM and ODM customers have contributed to the achievement of our record high quarterly revenue of ~~$187.0~~$208.5 million for the three months ended September 30, ~~2021,~~2022, a ~~23.4%~~11.5% growth compared to the same quarter last year.

On March 29, 2016, we formed a joint venture (the “JV Company”) with two investment funds owned by the Municipality of Chongqing (the “Chongqing Funds”), for the purpose of constructing and operating a power semiconductor packaging, testing and 12-inch wafer fabrication facility (“Fab”) in the LiangJiang New Area of Chongqing, China. The Fab is being built in phases. As of December 1, 2021, we owned 50.9%, and the Chongqing Funds owned 49.1% of the equity interest in the JV Company. The Joint Venture was accounted under the provisions of the consolidation guidance since we had controlling financial interest until December 1, 2021.

On December 24, 2021, the Company entered into a share transfer agreement with another third-party investor, pursuant to which the Company sold to this investor 1.1% of outstanding equity interest held by the Company in the JV Company. In addition, the JV Company adopted an employee equity incentive plan and issued an equity interest equivalent to 3.99% of the JV Company in exchange for cash. As a result of these two transactions, the Company owned 45.8% of the equity interest in the JV Company as of December 31, 2021.

On January 26, 2022, the JV Company completed a financing transaction pursuant to a corporate investment agreement (the “Investment Agreement”) between the JV Company and certain third-party investors (the “New Investors”). Under the Investment Agreement, the New Investors purchased newly issued equity interest of the JV Company, representing approximately 7.82% of post-transaction outstanding equity interests of the JV Company, for a total purchase price of RMB 509 million (or approximately USD 80 million based on the currency exchange rate as of January 26, 2022) (the “Investment”). Following the closing of the January 26, 2022 Investment, the percentage of outstanding JV equity interest beneficially owned by the Company was reduced to 42.2% at both June 30, 2022 and September 30, 2022.

We reduced our ownership of the JV Company to below 50% to increase the flexibility of the JV Company to raise capital to fund its future expansion. The JV Company is also contemplating an eventual listing on the Science and Technology Innovation Board, or STAR Market, of the Shanghai Stock Exchange. The reduction of our ownership assists the JV Company in meeting certain regulatory listing requirements. A potential STAR Market listing may take several years to consummate and there is no guarantee that such listing by the JV Company will be successful or will be completed in a timely manner, or at all. In addition, the JV Company will continue to provide us with significant level of foundry capacity to enable us to develop and manufacture our products. On July 12, 2022, the current shareholders of the JV Company entered into a shareholders contract, pursuant to which the JV Company provided us with a monthly wafer production capacity guarantee, subject to future increase when the JV Company’s production capacity reaches certain specified level.

Impact of COVID-19 Pandemic to our Business

Our business operations have been impacted by the global COVID-19 pandemic and the resulting economic downturn. Numerous governmental jurisdictions, including the States of California, Oregon and Texas in the U.S. and countries throughout the Asia Pacific region have imposed ~~“stay-at-home” orders, quarantines, travel bans and similar governmental orders and~~various restrictions ~~to control the spread of COVID-19. Such orders and restrictions have resulted~~on commercial activities, resulting in business closures, work stoppages, ~~slowdowns and delays in commercial activities, unprecedented and widespread unemployment,~~labor shortage, disruptions to ports, vaccine mandates and other shipping infrastructure, border closures, ~~and other travel or health-related restrictions,~~ thereby negatively impacting our customers, suppliers, distributors, employees, offices, and the entire semiconductor ecosystem.

As a result of the COVID-19 pandemic and changing consumer behaviors due to various government restrictions ~~including “stay-at-home” orders,~~and the growing trend to provide remote-working options by employers, we have experienced shifting market trends, including an increasing demand in markets for notebooks, ~~PCs,~~personal computing ("PC"), gaming devices and other products. While we have ~~recently~~ benefited from the increasing demand for PC related products, there is no guarantee that this trend will continue, and such increasing demand may discontinue or decline if government authorities relax or terminate COVID-19 related restrictions and consumer behaviors change in response to the reopening of certain economic activities. In an effort to protect the health and safety of our employees and to comply with various government and regulatory guidelines, we also took proactive actions to adopt policies and protocols at our locations around the world, including social distancing guidelines, ~~working from home, limiting the number of employees attending meetings, reducing the number of people in our sites at any one time,~~vaccine and ~~suspending employee travel, and these measures may result in difficulties and logistical challenges in our business operations.~~testing protocols.

~~Since~~During the ~~start~~first half of calendar year 2022, COVID-19 cases and hospitalization rate continued to decline and governments in various jurisdictions, including the ~~second quarter~~U.S. and Europe, have lifted various restrictions and limitations on economic activities. At the same time, however, new variants of ~~2021, there have been increasing availability~~COVID-19 continued to emerge and ~~administration~~contributed to recent rise of vaccines against COVID-19, as well as an easing of restrictions on social, business, travel, and government activities and functions, and a gradual resumption of economic activities and consumer spending in our industries. On the other hand, infection rates ~~continue to fluctuate~~ in various ~~regions~~jurisdictions in which we operate, including China and ~~new strains of~~U.S. Furthermore, we may be subject to the ~~virus remain a risk. In addition, there are~~ ongoing global impacts resulting from the pandemic, including disruption of the product supply chains, shortages of semiconductor components, and delays in shipments, product development, and product ~~launches.~~ launches and rising inflation rates.

Furthermore, our operations in China have been negatively impacted by the zero-Covid policy imposed by the Chinese government, which has resulted in lockdowns, mass testing and restrictions of travels and movement that limited our ability to conduct our business activities. See “Other Factors affecting our performance—Manufacturing costs and capacity availability”

The full extent of the ~~future~~longer-term impact of the COVID-19 pandemic on our operational and financial performance is uncertain and will depend on many factors outside our control, including, without limitation, the timing, extent, trajectory and duration of the pandemic; the availability, distribution and effectiveness of vaccines; the spread of new variants of COVID-19; the continued and renewed imposition of protective public safety ~~measures;~~measures, including local and regional lockdown and quarantines; the disruption of global supply chain; and the impact of the pandemic on the global economy and demand for consumer products. Although we are unable to predict the full impact and duration of the COVID-19 pandemic on our business, we are actively managing our business operations and financial expenditures in response to continued uncertainty.

2931

Other Factors affecting our performance

In addition to the COVID-19 pandemic and related events as described above, our performance is affected by several key factors, including the following:

The global, regional economic and PC market conditions: Because our products primarily serve consumer electronic applications, any significant change in global and regional economic conditions could materially affect our revenue and results of operations. ~~For example, because a~~A significant amount of our revenue is derived from sales of products in the ~~personal computing (“PC”)~~PC markets, such as notebooks, motherboards and notebook battery packs, therefore a substantial decline or downturn in the PC market could have a material adverse effect on our revenue and results of operations. The PC markets have experienced a modest global decline in recent years due to continued growth of demand in tablets and smart phones, worldwide economic conditions and the industry inventory correction which had and may continue to have a material impact on the demand for our products. However, we ~~recently~~ have experienced a significant increase of demand in PC market due to the impact of the COVID-19 pandemic and resulting shift in market trend and consumer behaviors. We cannot predict whether and how long this trend will continue due to the uncertainty and unpredictability of COVID-19 pandemic. A decline of the PC market may have a negative impact on our revenue, factory utilization, gross margin, our ability to resell excess inventory, and other performance measures. We have executed and continue to execute strategies to diversify our product portfolio, penetrate other market segments, including the consumer, communications and industrial markets, and improve gross margins and profit by implementing cost control measures. While making efforts to reduce our reliance on the computing market, we continue to support our computing business and capitalize on the opportunities in this market with a more focused and competitive PC product strategy to gain market share.

Manufacturing costs and capacity ~~availability~~availability: : Our gross margin is affected by a number of factors including our manufacturing costs, utilization of our manufacturing facilities, the product mixes of our sales, pricing of wafers from third party foundries and pricing of semiconductor raw materials. Capacity utilization affects our gross margin because we have certain fixed costs at our Shanghai facilities and our Oregon ~~fab and our Chongqing fabrication facility operated by the JV Company.~~Fab. If we are unable to utilize our manufacturing facilities at a desired level, our gross margin may be adversely affected. For example, in April 2022, the operations of our packaging and testing facilities in Shanghai, China were suspended due to a strict lockdown of the city imposed by the local government in response to surging COVID cases. We received permission to reopen our facilities partially in early May. We gradually ramped up production at these facilities in May and returned to normal operation in June 2022. However, there is no guarantee that additional restrictions and lockdown will not be reimposed by the government, which is outside of our control, and any extension of the lockdown will continue to have a negative impact on our results of operation and financial condition. In addition, from time to time, we may experience wafer capacity constraints, particularly at third party foundries, that may prevent us from meeting fully the demand of our customers. For example, the recent global shortage of semiconductor manufacturing capacity has provided us with both challenges and opportunities in the market, and highlighted the importance of maintaining sufficient and independent in-house manufacturing capabilities to meet increasing customer demands. While we can mitigate these constraints by increasing and re-allocating capacity at our own fab, we may not be able to do so quickly or at sufficient level, which could adversely affect our financial conditions and results of operations. In addition, we recently commenced a plan to enhance the manufacturing capability and capacity of our Oregon ~~fab~~Fab by investing in new equipment and expanding our factory facilities, which we expect will have a positive impact on our future new product development and revenue, particularly during the period of global shortage of capacity. The expansion is expected to be completed in the fiscal quarter ending March 31, 2023. We also rely substantially on the JV Company to provide foundry capacity to manufacture our products, therefore it is critical that we maintain continuous access to such capacity, which may not be available at sufficient level or at a pricing terms favorable to us ~~if our~~because of lack of control over the JV Company’s ~~operation is diminished. Our~~operation. As a result of sales of our JV Company equity interests and issuance of additional equity interests by the JV Company to third-party investors in financing transactions, our equity interest in the JV Company was reduced to 42.2%, which reduced our control ~~may be reduced~~and influence over the JV Company. We continue to maintain a business relationship with the JV Company to ensure uninterrupted supply of manufacturing capacity, and on July 12, 2022, we entered into an agreement with the JV Company, pursuant to which the JV Company agrees to provide us with a monthly wafer production capacity guarantee, subject to future increase when the JV Company’s production capacity reaches certain specified level. Because we continue to rely on the JV Company to provide us with manufacturing capacity, if the JV Company ~~completes an equity financing or/and issues more shares~~take actions or make decisions that ~~dilute~~prevents us from accessing required capacity, our ~~equity interests in the JV Company, or if the management of the JV Company operates more independently without our supervision.~~operations may be adversely affected.

Erosion and fluctuation of average selling price: Erosion of average selling prices of established products is typical in our industry. Consistent with this historical trend, we expect our average selling prices of existing products to decline in the future. However, in the normal course of business, we seek to offset the effect of declining average selling price by introducing new and higher value products, expanding existing products for new applications and new customers and reducing the manufacturing cost of existing products. These strategies may cause the average selling price of our products to fluctuate significantly from time to time, thereby affecting our financial performance and profitability.

Product introductions and customers’ product ~~requirements~~requirements: : Our success depends on our ability to introduce products on a timely basis that meet or are compatible with our customers' specifications and performance requirements. Both factors, timeliness of product introductions and conformance to customers' requirements, are equally important in securing design wins

with our customers. As we accelerate the development of new technology platforms, we expect to increase the pace at which we introduce new products and seek and acquire design wins. If we were to fail to introduce new products on a timely basis that meet customers’ specifications and performance requirements, particularly those products with major OEM customers, and continue to expand our serviceable markets, then we would lose market share and our financial performance would be adversely affected. We believe that the JV Transaction will increase and diversify our customer base, particularly in China, in the long term. However, the ramp-activities and production schedule of our JV Company have been impacted by the COVID-19 pandemic and related events, as discussed above. Even if we are able to ramp up the operation of the JV Company timely, we may not be successful in acquiring or maintaining a sufficient number of new customers to offset additional costs due to various factors, including but are not limited to, competition from other semiconductor companies in the region, our lack

~~of history and prior relationships with customers as a new entrant, difficulties in executing our joint venture strategies and the general economic conditions in Chongqing and China.~~

Distributor ordering patterns, customer demand and ~~seasonality~~seasonality:: Our distributors place purchase orders with us based on their forecasts of end customer demand, and this demand may vary significantly depending on the sales outlook and market and economic conditions of end customers. Because these forecasts may not be accurate, channel inventory held at our distributors may fluctuate significantly, which in turn may prompt distributors to make significant adjustments to their purchase orders placed with us. As a result, our revenue and operating results may fluctuate significantly from quarter to quarter. In addition, because our products are used in consumer electronics products, our revenue is subject to seasonality. Our sales seasonality is affected by numerous factors, including global and regional economic conditions as well as the PC market conditions, revenue generated from new products, changes in distributor ordering patterns in response to channel inventory adjustments and end customer demand for our products and fluctuations in consumer purchase patterns prior to major holiday seasons. In recent periods, broad fluctuations in the semiconductor markets and the global and regional economic conditions, in particular the decline of the PC market conditions, have had a more significant impact on our results of operations than seasonality. Furthermore, our revenue may be impacted by the level of demand from our major customers due to factors outside of our control. If these major customers experience significant decline in the demand of their products, encounter difficulties or defects in their products, or otherwise fail to execute their sales and marketing strategies successfully, it may adversely affect our revenue and results of operations.

~~Regulatory Matters~~:As previously disclosed, the DOJ commenced an investigation into our compliance with export control regulations relating to business transactions with Huawei, which were added to the “Entity List” by the DOC in May 2019. We continue to cooperate fully with federal authorities in the investigation. We have continued to respond to inquiries and requests from DOJ for documents and information relating to the investigation, and the matter is currently pending at DOJ. However, DOJ and DOC have not provided us any clear or definitive response regarding the timeline of the investigation and potential resolutions or outcome. In the meantime, we continue to incur significant costs and expenses, including legal and professional fees, in connection with the government investigation, which may reduce our profitability and operating margin.

Principal line items of statements of ~~operations~~income

The following describes the principal line items set forth in our ~~condensed consolidated statements~~Condensed Consolidated Statements of ~~operations:~~Income:

Revenue

We generate revenue primarily from the sale of power semiconductors, consisting of power discretes and power ICs. Historically, a majority of our revenue has been derived from power discrete products. Because our products typically have three-year to five-year life cycles, the rate of new product introduction is an important driver of revenue growth over time. We believe that expanding the breadth of our product portfolio is important to our business prospects, because it provides us with an opportunity to increase our total bill-of-materials within an electronic system and to address the power requirements of additional electronic systems. In addition, a small percentage of our total revenue is generated by providing packaging and testing services to third parties through one of our subsidiaries.

Our product revenue is reported net of the effect of the estimated stock rotation returns and price adjustments that we expect to provide to our distributors. Stock rotation returns are governed by contract and are limited to a specified percentage of the monetary value of products purchased by the distributor during a specified period. At our discretion or upon our direct negotiations with the original design manufacturers (“ODMs”) or original equipment manufacturers (“OEMs”), we may elect to grant special pricing that is below the prices at which we sold our products to the distributors. In these situations, we will grant price adjustments to the distributors reflecting such special pricing. We estimate the price adjustments for inventory at the distributors based on factors such as distributor inventory levels, pre-approved future distributor selling prices, distributor margins and demand for our products.

Cost of goods sold

Our cost of goods sold primarily consists of costs associated with semiconductor wafers, packaging and testing, personnel, including share-based compensation expense, overhead attributable to manufacturing, operations and procurement, and costs associated with yield improvements, capacity utilization, warranty and valuation of inventories. As the volume of sales increases, we expect cost of goods sold to increase. ~~We continued to ramp up the 12-inch fab at the JV Company to meet the increasing demand on our products.~~ While our utilization rates cannot be immune to the market conditions, our goal is to make them less vulnerable to market fluctuations. We believe our market diversification strategy and product growth will drive higher volume of manufacturing which will improve our factory utilization rates and gross margin in the long run.

Operating expenses

Our operating expenses consist of research and development, and selling, general and administrative ~~expenses and impairment of long-lived assets.~~expenses. We expect our operating expenses as a percentage of revenue to fluctuate from period to period as we continue to exercise cost control measures in response to the declining PC market as well as align our operating expenses to the revenue level.

Research and development ~~expenses.~~expenses. Our research and development expenses consist primarily of salaries, bonuses, benefits, share-based compensation expense, expenses associated with new product prototypes, travel expenses, fees for engineering services provided by outside contractors and consultants, amortization of software and design tools, depreciation of equipment and overhead costs. We continue to invest in developing new technologies and products utilizing our own fabrication and packaging facilities as it is critical to our long-term success. We also evaluate appropriate investment levels and stay focused on new product introductions to improve our competitiveness. We expect that our research and development expenses will fluctuate from time to time.

Selling, general and administrative expenses.Our selling, general and administrative expenses consist primarily of salaries, bonuses, benefits, share-based compensation expense, product promotion costs, occupancy costs, travel expenses, expenses related to sales and marketing activities, amortization of software, depreciation of equipment, maintenance costs and other expenses for general and administrative functions as well as costs for outside professional services, including legal, audit and accounting services. We expect our selling, general and administrative expenses to fluctuate in the near future as we continue to exercise cost control ~~measures~~measures.

Income tax expense

We are subject to income taxes in various jurisdictions. Significant judgment and estimates are required in determining our worldwide income tax expense. The calculation of tax liabilities involves dealing with uncertainties in the application of complex tax regulations of different jurisdictions globally. We establish accruals for potential liabilities and contingencies based on a more likely than not threshold to the recognition and de-recognition of uncertain tax positions. If the recognition threshold is met, the applicable accounting guidance permits us to recognize a tax benefit measured at the largest amount of tax benefit that is more likely than not to be realized upon settlement with a taxing authority. If the actual tax outcome of such exposures is different from the amounts that were initially recorded, the differences will impact the income tax and deferred tax provisions in the period in which such determination is made. Changes in the location of taxable income (loss) could result in significant changes in our income tax expense.

We record a valuation allowance against deferred tax assets if it is more likely than not that a portion of the deferred tax assets will not be realized, based on historical profitability and our estimate of future taxable income in a particular jurisdiction.Our judgments regarding future taxable income may change due to changes in market conditions, changes in tax laws, tax planning strategies or other factors.If our assumptions and consequently our estimates change in the future, the deferred tax assets may increase or decrease, resulting in corresponding changes in income tax expense.Our effective tax rate is highly dependent upon the geographic distribution of our worldwide profits or losses, the tax laws and regulations in each geographical region where we have operations, the availability of tax credits and carry-forwards and the effectiveness of our tax planning strategies.

~~U.S. Tax Cuts~~“The Chip and ~~Jobs~~Science Act of 2022”, Enacted ~~December 22, 2017~~August 2, 2022

OnIn August 2022 the U.S. enacted the Chip and Science Act of 2022 (the Chips Act). The Chips Act provides incentives to semiconductor chip manufacturers in the United States, including providing a 25% manufacturing investment credits for investments in semiconductor manufacturing property placed in service after December ~~22, 2017,~~31, 2022, for which construction begins before January 1, 2027. Property investments qualify for the 25% credit if, among other requirements, the property is integral to the operation of an advanced manufacturing facility, defined as having a primary purpose of manufacturing semiconductors or semiconductor manufacturing equipment. Currently, we are evaluating the impact of the Chips Act to us.

“The Inflation Reduction Act”, Enacted August 16, 2022

In August 2022 the United States enacted tax ~~reform~~ legislation through the ~~Tax Cuts and Jobs~~Inflation Reduction Act ~~(“the Tax Act”), which significantly changes the existing U.S. tax laws, including, but not limited to, (1)~~(IRA). The IRA introduces a ~~reduction in the corporate tax rate from 35% to 21%, (2) a shift from a worldwide tax system to a territorial system, (3) eliminating the~~15% corporate alternative minimum tax ~~(AMT) and changing how existing AMT credits can be realized, (4) bonus depreciation that will allow~~(CAMT) for ~~full expensing of qualified property, (5) creating a new limitation on deductible interest expense and (6) changing rules related to uses and limitations of net operating loss carryforwards created in~~corporations whose average annual adjusted financial statement income (AFSI) for any consecutive three-tax-year period preceding the applicable tax year exceeds $1 billion. The CAMT is effective for tax years beginning after December 31, ~~2017.~~

2022. The ~~company~~CAMT is currently not ~~currently subject~~applicable to the Base Erosion and Anti-Abuse ( BEAT) tax , which is a tax imposed on certain entities who make payments to their non US affiliates, where such payments reduce the US tax base . The BEAT tax is imposed at a rate of 10% on Adjusted Taxable Income, excluding certain payments to foreign related entities. It is an incremental tax over and above the corporate income tax and is recorded as a period cost. It is

~~possible that this tax could be applicable in future periods, which would cause an increase to the effective tax rate and cash taxes.~~

~~“U.S. Consolidated Appropriations Act, 2021” (“CAA 2021”), Enacted December 27, 2020~~Company.

3234

Equity method investment income/loss from equity investee

~~On December 27, 2020,~~We use the ~~United States enacted~~equity method of accounting when we have the ~~Consolidated Appropriations Act, 2021, which made changes~~ability to ~~existing U.S. tax laws. There was no material impact~~exercise significant influence, but we do not have control, as determined in accordance with generally accepted accounting principles, over the operating and financial policies of the ~~tax law changes included~~company. Effective December 2, 2021, we reduced our equity interest in the JV Company below 50% of outstanding equity ownership and experienced a loss of control of the JV Company. As a result, we record our investment under equity method of accounting. Since we are unable to obtain accurate financial information from the JV Company in a timely manner, we record our share of earnings or losses of such affiliate on a one quarter lag.

We record our interest in the net earnings of the equity method investee, along with adjustments for unrealized profits or losses on intra-entity transactions and amortization of basis differences, within earnings or loss from equity interests in the Consolidated ~~Appropriations Act, 2021~~Statements of Income. Profits or losses related to intra-entity sales with the ~~Company.~~

~~“The American Rescue Plan Act of 2021”, Enacted March 11, 2021~~

~~On March 11, 2021,~~equity method investee are eliminated until realized by the ~~United States enacted~~investor or investee. Basis differences represent differences between the ~~American Rescue Plan Act of 2021, which made changes to existing U.S. tax laws. There was no material impact~~cost of the ~~tax law changes included~~investment and the underlying equity in net assets of the investment and are generally amortized over the lives of the related assets that gave rise to them. Equity method goodwill is not amortized or tested for impairment. Instead the total equity method investment balance, including equity method goodwill, is tested for impairment. We review for impairment whenever factors indicate that the carrying amount of the investment might not be recoverable. In such a case, the decrease in value is recognized in the ~~American Rescue Plan Act~~period the impairment occurs in the Consolidated Statement of ~~2021 to the Company.~~Income.

Results of Operations

The following tables set forth statements of ~~operations,~~income, also expressed as a percentage of revenue, for the three months ended September 30, ~~2021~~2022 and ~~2020.~~2021. Our historical results of operations are not necessarily indicative of the results for any future period.


		Three Months Ended September 30,								Three Months Ended September 30,
		2021		2020		2021		2020					2022		2021		2022		2021
		(in thousands)				(% of revenue)					(in thousands)		(% of revenue)
Revenue	Revenue	$	187,035	$	151,551	100.0	%	100.0	%			Revenue	$	208,476	$	187,035	100.0	%	100.0	%
Cost of goods sold	Cost of goods sold	122,468		109,028		65.5	%	71.9	%			Cost of goods sold	137,348		122,468		65.9	%	65.5	%
Gross profit	Gross profit	64,567		42,523		34.5	%	28.1	%			Gross profit	71,128		64,567		34.1	%	34.5	%
Operating expenses	Operating expenses											Operating expenses
Research and development	Research and development	17,812		14,691		9.5	%	9.7	%			Research and development	21,389		17,812		10.3	%	9.5	%
Selling, general and administrative	Selling, general and administrative	21,806		17,505		11.7	%	11.6	%			Selling, general and administrative	24,205		21,806		11.6	%	11.7	%

Total operating expenses	Total operating expenses	39,618		32,196		21.2	%	21.3	%			Total operating expenses	45,594		39,618		21.9	%	21.2	%
Operating income	Operating income	24,949		10,327		13.3	%	6.8	%			Operating income	25,534		24,949		12.2	%	13.3	%
Interest expense and other income (loss), net		(2,192)		(549)		(1.3)	%	(0.3)	%

Other income (loss), net												Other income (loss), net	(16)		(16)		—	%	—	%
Interest expense, net												Interest expense, net	(608)		(2,176)		(0.3)	%	(1.3)	%

Income before income taxes		22,757		9,778		12.0	%	6.5	%
Net income before income taxes												Net income before income taxes	24,910		22,757		11.9	%	12.0	%
Income tax expense	Income tax expense	1,320		1,011		0.7	%	0.7	%			Income tax expense	1,374		1,320		0.6	%	0.7	%
Net income including noncontrolling interest		21,437		8,767		11.3	%	5.8	%
Net income before income from equity method investment												Net income before income from equity method investment	23,536		21,437		11.3	%	11.3	%
Equity method investment income from equity investee												Equity method investment income from equity investee	2,502		—		1.2	%	—	%
Net income												Net income	26,038		21,437		12.5	%	11.3	%
Net loss attributable to noncontrolling interest	Net loss attributable to noncontrolling interest	(1,987)		(807)		(1.1)	%	(0.5)	%			Net loss attributable to noncontrolling interest	—		(1,987)		—	%	(1.1)	%
Net income attributable to Alpha and Omega Semiconductor Limited	Net income attributable to Alpha and Omega Semiconductor Limited	$	23,424	$	9,574	12.4	%	6.3	%			Net income attributable to Alpha and Omega Semiconductor Limited	$	26,038	$	23,424	12.5	%	12.4	%

Share-based compensation expense was recorded as follows:


		Three Months Ended September 30,								Three Months Ended September 30,
		2021		2020		2021		2020					2022		2021		2022		2021
		(in thousands)				(% of revenue)					(in thousands)		(% of revenue)
Cost of goods sold	Cost of goods sold	$	569	$	385	0.3	%	0.3	%			Cost of goods sold	$	1,788	$	569	0.9	%	0.3	%
Research and development	Research and development	1,043		1,080		0.6	%	0.7	%			Research and development	2,494		1,043		1.2	%	0.6	%
Selling, general and administrative	Selling, general and administrative	3,023		1,411		1.6	%	0.9	%			Selling, general and administrative	6,314		3,023		3.0	%	1.6	%
Total	Total	$	4,635	$	2,876	2.5	%	1.9	%			Total	$	10,596	$	4,635	5.1	%	2.5	%

Three Months Ended September 30, ~~2021~~2022 and ~~2020~~2021

Revenue

The following is a summary of revenue by product type:


		Three Months Ended September 30,								Three Months Ended September 30,
		2021		2020		Change					2022		2021		Change
		(in thousands)				(in thousands)		(in percentage)			(in thousands)				(in thousands)		(in percentage)
Power discrete	Power discrete	$	130,688	$	119,375	$	11,313	9.5	%			Power discrete	$	145,139	$	130,688	$	14,451	11.1	%
Power IC	Power IC	52,330		29,455		22,875		77.7	%			Power IC	61,754		52,330		9,424		18.0	%
Packaging and testing services	Packaging and testing services	4,017		2,721		1,296		47.6	%			Packaging and testing services	1,583		4,017		(2,434)		(60.6)	%
		$	187,035	$	151,551	$	35,484	23.4	%				$	208,476	$	187,035	$	21,441	11.5	%

Total revenue was ~~$187.0~~was $208.5 million forfor the three months ended September 30, ~~2021,~~2022, an increase of ~~$35.5~~$21.4 million, or ~~23.4%~~11.5%, as compared to ~~$151.6~~$187.0 million for the same quarter last year.The increase was primarily due to an increase of ~~$11.3~~ $14.5 million and ~~$22.9~~$9.4 million in sales of power discrete products and sales of power IC products, respectively. The increase in power discrete and power IC product sales was primarily due to a ~~39.7%~~44.1% increase ~~in unit shipments, partially offset by an 8.4% decrease~~ in average selling price, offset by a 21.5% decrease in unit shipments as compared to same quarter last year due to a shift in product mix. The ~~increase~~decrease in revenue of packaging and testing services for the three months ended September 30, ~~2021,~~2022, as compared to same quarter last year, was primarily due to ~~increased~~decreased demand.

Cost of goods sold and gross profit

Three Months Ended September 30,
2021 2020 Change
(in thousands) (in thousands) (in percentage)
Cost of goods sold $ 122,468 $ 109,028 $ 13,440 12.3 %
Percentage of revenue 65.5 % 71.9 %
Gross profit $ 64,567 $ 42,523 $ 22,044 51.8 %
Percentage of revenue 34.5 % 28.1 %


	Three Months Ended September 30,
	2022			2021			Change
	(in thousands)						(in thousands)		(in percentage)
Cost of goods sold	$	137,348		$	122,468		$	14,880	12.2	%
Percentage of revenue	65.9		%	65.5		%

Gross profit	$	71,128		$	64,567		$	6,561	10.2	%
Percentage of revenue	34.1		%	34.5		%

Cost of goods sold was ~~$122.5~~$137.3 million for the three months ended September 30, ~~2021,~~2022, an increase of ~~$13.4~~$14.9 million, or ~~12.3%~~12.2%, as compared to ~~$109.0~~$122.5 million for the same quarter last year. The increase was primarily due to ~~23.4%~~11.5% increase in revenue. Gross margin ~~increased~~decreased by ~~6.4~~0.4 percentage points to ~~34.5%~~34.1% for the three months ended September 30, ~~2021,~~2022, as compared to ~~28.1%~~34.5% for the same quarter last year. ~~Our JV Company continued its ramp~~ The decrease in gross margin was primarily due to higher material costs and less unit shipment during the three months ended September 30, ~~2021, which resulted in an increase in the capacity utilization and contributed to the increase in gross margin during the three months ended September 30, 2021.~~2022.

3436

Research and development expenses

Three Months Ended September 30,
2021 2020 Change
(in thousands) (in thousands) (in percentage)
$ 17,812 $ 14,691 $ 3,121 21.2 %


	Three Months Ended September 30,
	2022		2021		Change
	(in thousands)				(in thousands)		(in percentage)
Research and development expenses	$	21,389	$	17,812	$	3,577	20.1	%

Research and development expenses were ~~$17.8~~$21.4 million for the three months ended September 30, ~~2021,~~2022, an increase of ~~$3.1~~$3.6 million, or ~~21.2%~~20.1%, as compared to ~~$14.7~~$17.8 million for the same quarter last year. The increase was primarily attributable to ~~a $2.7~~$0.6 million increase in employee compensation and ~~benefits~~benefit expense mainly due to ~~higher bonuses~~increased headcount and annual merit increase, partially offset by lower bonus accrual, a ~~$0.2~~$1.5 million increase in share-based compensation expense due to an increase in stock awards granted, a $0.7 million increase in depreciation expenses, and a $1.0 million increase in product prototyping engineering expense as a result of increased engineering activities, ~~and~~offset by a ~~$0.1~~$0.2 million ~~increase~~decrease in ~~depreciation expenses during the current quarter.~~consulting fees.

Selling, general and administrative expenses

Three Months Ended September 30,
2021 2020 Change
(in thousands) (in thousands) (in percentage)
Selling, general and administrative $ 21,806 $ 17,505 $ 4,301 24.6 %


	Three Months Ended September 30,
	2022		2021		Change
	(in thousands)				(in thousands)		(in percentage)
Selling, general and administrative	$	24,205	$	21,806	$	2,399	11.0	%

Selling, general and administrative expenses ~~were $21.8~~were $24.2 million for the three months ended September 30, ~~2021,~~2022, an increase of ~~$4.3~~$2.4 million, or ~~24.6%~~11.0%, as compared to ~~$17.5~~$21.8 million for the same quarter last ~~year~~.year. The increase was primarily ~~attributable~~due to a ~~$4.2 million increase in employee compensation and benefits expenses mainly due to higher bonus expenses accrual and increased business insurance expenses,~~ ~~as well as $1.6~~$3.3 million increase in share-based compensation expense due to ~~higher~~an increase in stock ~~rewards price.~~ ~~The increase was~~award granted, a $0.3 million in audit fees and a $0.3 million in design wins costs, partially offset by a ~~$0.7~~$1.6 million decrease in ~~legal expense related~~employee compensation and benefits expenses primarily due to ~~the government investigation, a $0.2 million decrease in marketing demo~~lower bonus expenses accrual, partially offset by increased headcount, annual merit increase and ~~trade shows costs as a result of the COVID-19 pandemic, and a $0.5 million decrease in audit and tax consulting fees during the current quarter.~~higher medical insurance expenses.

~~Interest expense and other~~Other income (loss), net

Three Months Ended September 30,
2021 2020 Change
(in thousands) (in thousands) (in percentage)
Interest expense and other income (loss), net $ (2,192) $ (549) $ (1,643) 299.3 %


	Three Months Ended September 30,
	2022		2021		Change
	(in thousands)				(in thousands)		(in percentage)
Other income (loss), net	$	(16)	$	(16)	$	—	—	%

Other income (loss), net for the three months ended September 30, 2022 and 2021 did not change.

Interest expense, net


	Three Months Ended September 30,
	2022		2021		Change
	(in thousands)				(in thousands)		(in percentage)
Interest expense, net	$	(608)	$	(2,176)	$	1,568	(72.1)	%

Interest expense, ~~was primarily related to bank borrowings. Interest expense increased~~net decreased by ~~$0.5~~$1.6 million during the three months ended September 30, ~~2021~~2022 as compared to the same ~~period~~quarter last year was primarily due to ~~an increase in bank borrowings, as well as an interest refund from the Chinese government in~~deconsolidation of the JV Company in ~~the same period last year.~~December 2021.

Interest income and others were primarily related to interest earned from cash and cash equivalents, as well as foreign exchange gains (losses). Interest income and others, net decreased by $1.1 million during the three months ended September 30, 2021 as compared to the same period last year was primarily due to lower foreign currency exchange gains as a result of the depreciation of RMB against USD.

Income tax expense
Three Months Ended September 30,
2021 2020 Change
(in thousands) (in thousands) (in percentage)
Income tax expense $ 1,320 $ 1,011 $ 309 30.6 %


	Three Months Ended September 30,
	2022		2021		Change
	(in thousands)				(in thousands)		(in percentage)
Income tax expense	$	1,374	$	1,320	$	54	4.1	%

2021 included ~~a $.09~~$0.09 million discrete tax expense. ~~The income tax expense of $1.0 million for the three months ended September 30, 2020 included a $0.03 million discrete tax benefit.~~ Excluding the discrete income tax items, the effective tax rate for the three months ended September 30, 2022 and 2021 was 4.8% and ~~2020 was~~ 5.4% ~~and 10.7%~~, respectively. The changes in the tax expense and effective tax rate ~~and tax expense~~ between the periods resulted primarily from changes in the mix of earnings in various geographic jurisdictions between the current year and the same period of last year.

The Company files its income tax returns in the United States and in various foreign jurisdictions. The tax years 2001 to 2022 remain open to examination by U.S. federal and state tax authorities. The tax years 2014 to 2022 remain open to examination by foreign tax authorities.

The Company's income tax returns are subject to examinations by the Internal Revenue Service and other tax authorities in various jurisdictions. In accordance with the guidance on the accounting for uncertainty in income taxes, the Company ~~reporting pretax book~~regularly assesses the likelihood of adverse outcomes resulting from these examinations to determine the adequacy of its provision for income taxes. These assessments can require considerable estimates and judgments. As of ~~$22.8 million for the three months ended~~ September 30, ~~2021 as compared~~2022, the gross amount of unrecognized tax benefits was approximately $8.6 million, of which $5.6 million, if recognized, would reduce the effective income tax rate in future periods. If the Company's estimate of income tax liabilities proves to be less than the ultimate assessment, then a ~~pretax book income~~further charge to expense would be required. If the payment of ~~$9.8 million for~~these amounts ultimately proves to be unnecessary, the ~~three months ended September 30, 2020.~~reversal of the liabilities would result in tax benefits being recognized in the period when the Company determines the liabilities are no longer necessary. The Company does not anticipate any material changes to its uncertain tax positions during the next twelve months.

Liquidity and Capital Resources

Our principal need for liquidity and capital resources is to maintain sufficient working capital to support our operations and to invest adequate capital expenditures to grow our business. To date, we finance our operations and capital expenditures primarily through funds generated from operations and borrowings under our term loans, financing lease and other debt agreements.

In September 2021, Jireh Semiconductor Incorporated (“Jireh”), one of the wholly-owned subsidiaries, entered into a financing arrangement agreement with a company (“Lender”) for the lease and purchase of a machinery equipment manufactured by a supplier. This agreement has a 5 years term, after which Jireh has the option to purchase the equipment for $1. The implied interest rate was 4.75% per annum which was adjustable based on every five basis point increase in 60-month U.S. Treasury Notes, until the final installation and acceptance of the machine. The total purchase price of this machinery equipment was euro 12.0 million, or $12.8 million based on the currency exchange rate between the euro and U.S. Dollar on June 30, 2022. In April 2021, Jireh made a down payment of euro 6.0 million, representing 50% of the total purchase price of the equipment, to the supplier. In June 2022, the equipment was delivered to Jireh after Lender paid 40% of the total purchase price, for euro 4.8 million, to the supplier on behalf of Jireh. In September 2022, Lender paid the remaining 10% payment for the total purchase price and reimbursed Jireh for the 50% down payment, after the installation and configuration of the equipment. The title of the equipment was transferred to Lender following such payment. The agreement was amended with fixed implied interest rate of 7.51% and monthly payment of principal and interest effective in October 2022. Other terms remain the same. In addition, Jireh purchased hardware for the machine under this financing arrangement. The purchase price of this hardware was $0.2 million. The financing arrangement is secured by this machinery equipment and the hardware which had the carrying amount of $13.1 million as of September 30, 2022. As of September 30, 2022, the outstanding balance of this debt financing was $13.4 million.

On August 18, 2021, Jireh entered into a term loan agreement with a financial institution (the "Bank") in an amount up to $45.0 million for the purpose of expanding and upgrading the Company’s fabrication facility located in Oregon. The obligation under the loan agreement is secured by substantially all assets of Jireh and guaranteed by the Company. The agreement has a 5.5 year term and matures on February 16, 2027. Jireh is required to make consecutive quarterly payments of principal and interest. The loan accrues interest based on adjusted LIBOR plus the applicable margin based on the outstanding balance of the

loan. This agreement contains customary restrictive covenants and includes certain financial covenants that ~~require~~ the Company is required to maintain. Jireh drew down $45.0 million on February 16, 2022 with the first payment of principal beginning in October 2022. As of September 30, ~~2021, there~~ 2022, Jireh was ~~no outstanding~~in compliance with these covenants and the outstanding balance ~~under the loan.~~of this loan was $45.0 million.

OnIn October 2019, one of the Company's ~~subsidiary~~subsidiaries in China entered into a line of credit facility with Bank of Communications Limited in China. This line of credit ~~matures~~matured on February 14, 2021 and iswas based on the China Base Rate multiplied by 1.05, or 4.99% on October 31, 2019. The purpose of the credit facility is to provide short-term borrowings. The Company could borrow up to approximately RMB 60.0 million or $8.5 million based on the currency exchange rate between the RMB and the U.S. Dollar on October 31, 2019. In September 2021, this line of credit was renewed with maximum borrowings up to RMB 140.0 million with the same terms and a credit maturity date of September 18, 2022. During the three months ended December 31, 2021, the Company borrowed RMB 11.0 million, or $1.6 million, at an interest rate of 3.85% per annum, with principal due on November 18, 2022. As of September 30, 2022, the total outstanding balance of this loan was $1.5 million.

On August 9, 2019, one of the Company's wholly-owned subsidiaries (the “Borrower”) entered into a factoring agreement with the Hongkong and Shanghai Banking Corporation Limited (“HSBC”), whereby the Borrower assigns certain of its accounts receivable with recourse. This factoring agreement allows the Borrower to borrow up to 70% of the net amount of its eligible accounts receivable of the Borrower with a maximum amount of $30.0 million. The interest rate is based on one month London Interbank Offered Rate (“LIBOR”) plus 1.75% per annum. The Company is the guarantor for this agreement. The Company is accounting for this transaction as a secured borrowing under the Transfers and Servicing of Financial Assets guidance. In addition, any cash held in the restricted bank account controlled by HSBC has a legal right of offset against the borrowing. This agreement, with certain financial covenants required, has no expiration date. On August 11, 2021, the Borrower signed an agreement with HSBC to decrease the borrowing maximum amount to $8.0 million with certain financial covenants required. Other terms remain the same. As of September 30, 2022, the Borrower was in compliance with these covenants. As of September 30, 2022, there was no outstanding balance ~~under~~and the ~~loan.~~Company had unused credit of approximately $8.0 million.

On November 16, 2018, the Company's subsidiary in China entered into a line of credit facility with Industrial and Commercial Bank of China. The purpose of the credit facility was to provide short-term borrowings. The Company could borrow up to approximately RMB 72.0 million or $10.3 million based on currency exchange rate between RMB and U.S. Dollar on November 16, 2018. The RMB 72.0 million consists of RMB 27.0 million for trade borrowings with a maturity date of December 31, 2021, and RMB 45.0 million for working capital borrowings or trade borrowings with a maturity date of September 13, 2022. During the three months ended December 31, 2021, the Company borrowed RMB 5.0 million, or $0.8 million, at an interest rate of 3.7% per annum, with principal due on September 12, 2022. As of September 30, ~~2021,~~2022, there was no outstanding ~~balance under the loan.~~

On August 9, 2019, one of the Company's wholly-owned subsidiaries (the "Borrower") entered into a factoring agreement with the Hongkong and Shanghai Banking Corporation Limited ("HSBC"), whereby the Borrower assigns certain of its accounts receivable with recourse. This factoring agreement allows the Borrower to borrow up to 70% of the net amount of its eligible accounts receivable of the Borrower with a maximum amount of $30.0 million. The interest rate is based on one month London Interbank Offered Rate ("LIBOR") plus 1.75% per annum. The Company is the guarantor for this agreement. The Company is accounting for this transaction as a secured borrowing under the Transfers and Servicing of Financial Assets guidance. In addition, any cash held in the restricted bank account controlled by HSBC has a legal right of offset against the borrowing. This agreement, with certain financial covenants required, has no expiration date. On August 11, 2021, the Borrower signed an agreement with HSBC to decrease the borrowing maximum amount to $8.0 million with certain financial covenants required. Other terms remain the same. As of September 30, 2021, the Borrower was in compliance with these covenants. ~~As of September 30, 2021, there was~~ no ~~outstanding balance and the Company had unused credit of approximately $8.0 million.~~balance.

On May 1, 2018, Jireh ~~Semiconductor Incorporated ("Jireh"), a wholly-owned subsidiary of the Company,~~ entered into a loan agreement with ~~a financial institution (the "Bank")~~the Bank that provided a term loan in the amount of $17.8 million. The obligation under the loan agreement is secured by certain real estate assets of Jireh and guaranteed by the Company. The loan has a five-year term and matures on June 1, 2023. Beginning June 1, 2018, Jireh made consecutive monthly payments of principal and interest to the Bank. The outstanding principal accrues interest at a fixed rate of 5.04% per annum on the basis of a 360-day year. The loan agreement contains customary restrictive covenants and includes certain financial covenants that require the Company to maintain, on a consolidated basis, specified financial ratios. In August 2021, Jireh signed an amendment of this loan with the Bank to modify the financial covenants requirement to align with the new term loan agreement entered into on August 18, 2021 discussed above. The amendment was accounted for as a debt modification and no gain or loss

was recognized. The Company was in compliance with these covenants as of September 30, ~~2021.~~2022. As of September 30, ~~2021,~~2022, the outstanding balance of the term ~~loa~~nloan was ~~$14.8~~$13.9 million.

On August 15, 2017, Jireh entered into a credit agreement with the Bank that provided a term loan in an amount up to $30.0 million for the purpose of purchasing certain equipment for the ~~Company's~~Company’s fabrication facility located in Oregon. The obligation under the credit agreement is secured by substantially all assets of Jireh and guaranteed by the Company. The credit agreement has a five-year term and ~~matures~~matured on August 15, 2022. In January 2018 and July 2018, Jireh drew down the loan in the amount of $13.2 million and $16.7 million, respectively. Beginning in October 2018, Jireh is required to pay to the Bank on each payment date, the outstanding principal amount of the loan in monthly installments. The loan accrues interest based on an adjusted LIBOR as defined in the credit agreement, plus a specified applicable margin in the range of 1.75% to 2.25%, based on the outstanding balance of the loan. The credit agreement contains customary restrictive covenants and includes certain financial covenants that require the Company to maintain, on a consolidated basis, specified financial ratios and fixed charge coverage ratio. In August 2021, Jireh signed an amendment of this loan with the Bank to modify the financial covenants requirement to align with the new term loan agreement entered into on August 18, 2021, discussed above. The amendment was accounted for as a debt modification and no gain or loss was recognized. The Company was in compliance with these covenants as of September 30, ~~2021.~~2022. As of September 30, ~~2021, the~~2022, there was no outstanding ~~balance of the term loan~~ balance.

~~was~~ ~~$7.5 million.~~

In September 2017, the Board of Directors approved a repurchase program (the “Repurchase Program”) that allowed us to repurchase our common shares from the open market pursuant to a pre-established Rule 10b5-1 trading plan or through privately negotiated transactions up to an aggregate of $30.0 million. The amount and timing of any repurchases under the Repurchase Program depend on a number of factors, including but not limited to, the trading price, volume and availability of our common shares. Shares repurchased under this program are accounted for as treasury shares and the total cost of shares repurchased is recorded as a reduction of shareholders’ equity. We did not repurchase any shares pursuant to the Repurchase Plan during the three months ended September 30, 2021. Since the inception of the program, we repurchased an aggregate of 6,784,648 shares for a total cost of $67.3 million, at an average price of $9.92 per share, excluding fees and related expenses. As of September 30, 2021, of the 6,784,648 repurchased shares, 161,145 shares with a weighted average repurchase price of $10.13 per share, were reissued at an average price of $5.19 per share pursuant to option exercises and vested restricted share units. We had $13.4 million remained ~~available under the Repurchase Program as of September 30, 2021.~~

We believe that our current cash and cash equivalents and cash flows from operations will be sufficient to meet our anticipated cash needs, including working capital and capital expenditures, for at least the next twelve months. In addition, we commenced an investment plan to expand the manufacturing capacity and upgrade the operational capabilities of our Oregon Fab. We intend to fund the costs by a combination of cash reserve, bank loans and equipment leases. In the long-term, we may require additional capital due to changing business conditions or other future developments, including any investments or acquisitions we may decide to pursue. If our cash is insufficient to meet our needs, we may seek to raise capital through equity or debt financing. The sale of additional equity securities could result in dilution to our shareholders. The incurrence of indebtedness would result in increased debt service obligations and may include operating and financial covenants that would restrict our operations. We cannot be certain that any financing will be available in the amounts we need or on terms acceptable to us, if at all.

~~JV Company Financing Transactions~~

From time to time the JV Company entered into financing and loan agreements with banks and other third parties to fund capital expenditures and other operational expenses in connection with the constructions and ramp-up of the manufacturing facility in Chongqing. The JV Company incurs debt through its own financing agreements, and our parent company and other subsidiaries are not parties to these agreements and do not provide any guarantee or security for JV Company’s debt, nor do we have direct access to any cash proceeds borrowed from such loan agreements.

On May 9, 2018 (the “Effective Date”), the JV Company entered into a lease finance agreement and a security agreement (the “Agreements”) with YinHai Leasing Company and China Import/Export Bank (the “Lenders”). Pursuant to the Agreements, the Lenders agreed to provide an aggregate of RMB 400.0 million, or $62.8 million based on the currency exchange rate between RMB and U.S. Dollar on the Effective Date, of financing to the JV Company (the “Lease Financing”). In exchange for the Lease Financing, the JV Company agreed to transfer title of its assembly and testing equipment to the Lenders, and the Lenders leased such equipment to the JV Company under a five-year lease arrangement, pursuant to which the JV Company makes quarterly lease payments to the Lenders consisting of principal and interest based on a repayment schedule mutually agreed by the parties. The interest under the Lease Financing is accrued based on the China Base Rate multiplied by 1.15, or 5.4625% on the Effective Date. Under the Agreements, at the end of the five-year lease term, the Lenders agree to sell such equipment back to the JV Company for a nominal amount (RMB 1). The JV Company’s obligations under the Lease Financing are secured by the land and building owned by the JV Company (the “Collateral”). The proceeds from the Lease Financing were used primarily for the acquisition and installation of the 12-inch fabrication equipment and other expenses of the JV Company relating to the completion of the fabrication facility located in Chongqing. The Agreements contain customary representation, warranties and covenants, including restrictions on the transfer of the Collateral. The Agreements also contain

customary events of default, including but not limited to, failure to make payments and breach of material terms under the Agreements. The Agreements include certain customary closing conditions, including the payment of deposit by the JV Company. On June 28, 2020, the parties entered into a modification to this agreement, pursuant to which the interest rate was changed to be the five-year loan prime rate in China plus 0.8125%, or 5.4625%. Other terms of this agreement remain the same. As of September 30, 2021, the outstanding balance of the Lease Financ~~ing of~~ ~~163.0 million RMB (equivalent of~~ ~~$25.2 million~~ ~~based on the currency exchange rate as of September 30, 2021) was recorded under short-term and long-term finance lease liabilities.~~

On March 12, 2019, the JV Company entered into a loan agreement with The Export-Import Bank of China in the aggregate principal amount of RMB 200.0 million (approximately $29.8 million based on currency exchange rate between RMB and U.S. Dollar on March 31, 2019). The loan will mature on February 20, 2025. ~~The JV Company drew down RMB 190.0 million and RMB 10.0 million in March 2019 and December 2019, respectively. The l~~oan withdraw window expired on February 28, 2020. The interest is accrued based on the China Base Rate multiplied by 1.1, or 5.39%. The loan requires quarterly interest payments. The principal payments are required to be paid every 6 months over the term of loan commencing in October 2019. This loan is secured by the buildings and certain equipment owned by the JV Company with a carrying value of $88.1 million as of September 30, 2021. As a condition of the loan arrangement, RMB 14.0 million (approximately $2.0 million) of cash is held as restricted cash by the JV Company as a compensating balance at the bank until the principal is paid. On June 24, 2020, a modification of this loan was signed, pursuant to which the interest rate was changed to be based on the five-year loan prime rate in China plus 0.74%, or 5.39%. Other terms of this loan remain the same. As of September 30, 2021, the outstanding balance of the loan was RMB 184.0 million~~(equivalent of~~ ~~$28.5 million based on the currency exchange rate as of September 30, 2021).~~

On April 26, 2020, the JV Company entered into a loan agreement with China Development Bank, Agricultural Bank of China, China Merchants Bank and Chongqing Rural Commercial Bank (collectively, the “Banks”) in the aggregate principal amount of RMB 250 million (approximately $35.7 million based on the currency exchange rate between RMB and U.S. Dollar on April 26, 2020). The obligation under the loan agreement is secured by certain assets of the JV Company. The obligation under the loan agreement is secured by certain assets of the JV Company with a carrying value of $111.7 million as of September 30, 2021. The JV Company is required to make consecutive semi-annual payments of principal until December 8, 2024. Interest payments are due on March 20, June 20, September 20 and December 20 of each year based o~~n the LPR plus 1.3%. The JV Company drew down RMB 250.0 million (approximately $35.3 million based on the currency exchange rate~~ ~~between RMB and U.S. Dollar on June 30, 2020) in April 2020. As of September 30, 2021, the outstanding balance of the loan~~ ~~was $34.1 million.~~

On April 19, 2021, the JV Company entered into a loan agreement with China Everbright Bank in China to borrow a maximum of RMB 100 million. The borrowing can be in RMB or U.S. Dollar (“USD”). The loan consists of RMB 50 million for working capital borrowings in Chinese yuan and RMB 50 million for borrowing in USD. The loan is collateralized by eligible accounts receivable. On April 19, 2021, the JV Company borrowed RMB 50.0 million, or $7.7 million based on the currency exchange rate between RMB and USD on April 19, 2021, at an interest rate of 5.1% per annum. The interest payments are due quarterly with the entire principal due no later than May 19, 2022. On June 16, 2021 and June 24, 2021, the JV Company borrowed $4.2 million and $3.5 million at interest rate of 2.7% per annum, and repaid in full during the quarter ended September 30, 2021. On August 17, 2021 and September 22, 2021, the JV Company also borrowed $4.2 million and $3.4 million at interest rate of 2.7% per annum, with principal due on November 9, 2021 and December 12, 2021, respectively. As of September 30, 2021, the total outstanding balance of these loans was $15.3 million.

On June 29, 2021, the JV Company entered into a P1Y-year loan agreement with China CITIC Bank in China to borrow a maximum of $7.7 million. Interest payments are due on the 20th of each quarter commencing on September 20, 2021, and the

~~entire principal is due on June 29, 2022. As of September 30, 2021, the outstanding balance of this loan was $7.7 million at an interest rate of 3.49% per annum.~~

Cash, cash equivalents and restricted cash

As of September 30, ~~2021~~2022 and June 30, ~~2021,~~2022, we had~~$255.0 million~~ a~~nd $204.8~~$316.4 million and $314.7 million of cash, cash equivalents and restricted cash, respectively. Our cash, cash equivalents and restricted cash primarily consist of cash on hand, restricted cash, and short-term bank deposits with original maturities of three months or less. Of the ~~$255.0~~ $316.4 million and ~~$204.8~~$314.7 million cash, cash equivalents and restricted cash, ~~$225.8~~$263.0 million and ~~$134.6~~$212.6 million, respectively, are deposited with financial institutions outside the United States.

The following table shows our cash flows from operating, investing and financing activities for the periods indicated:


		Three Months Ended September 30,					Three Months Ended September 30,
		2021		2020			2022		2021
		(in thousands)					(in thousands)
Net cash provided by operating activities	Net cash provided by operating activities	$	80,607	$	9,848	Net cash provided by operating activities	$	36,675	$	80,607
Net cash used in investing activities	Net cash used in investing activities	(23,911)		(11,337)		Net cash used in investing activities	(39,974)		(23,911)
Net cash used in financing activities		(6,535)		(4,186)
Net cash provided by (used in) financing activities						Net cash provided by (used in) financing activities	5,462		(6,535)
Effect of exchange rate changes on cash, cash equivalents and restricted cash	Effect of exchange rate changes on cash, cash equivalents and restricted cash	(11)		1,997		Effect of exchange rate changes on cash, cash equivalents and restricted cash	(417)		(11)

Net increase (decrease) in cash, cash equivalents and restricted cash		$	50,150	$	(3,678)
Net increase in cash, cash equivalents and restricted cash						Net increase in cash, cash equivalents and restricted cash	$	1,746	$	50,150

Cash flows from operating activities

Net cash provided by operating activities of $36.7 million for the three months ended September 30, 2022 resulted primarily from net income of $26.0 million and non-cash expenses of $17.7 million, partially offset by net changes in assets and liabilities using cash of $7.1 million, The non-cash expenses of $17.7 million primarily included $10.6 million of share-based compensation expense, $9.4 million of depreciation and amortization expenses, $0.4 million of loss on disposal of property and equipment, and $2.5 million of income on equity investment. The net changes in assets and liabilities of $7.1 million were primarily due to a $9.5 million decrease in other payable from equity investee, a $6.0 million decrease in accounts payable due to timing of payments, a $6.9 million increase in inventories as a result of our inventories built up for preparation of uncertainty of supply chains, and a $0.5 million increase in other current and long-term assets due to increase in advance payments to vendors, partially offset by a $9.9 million decrease in accounts receivable as a result of timing of the shipments and payments collected, a $0.5 million increase in income taxes payable, and a $5.5 million increase in accrued and other liabilities.

Net cash provided by operating activities of $80.6 million for the three months ended September 30, 2021 resulted primarily from net income of $21.4 million and non-cash expenses of $19.0 million, partially offset by net changes in assets and liabilities using cash of $40.1 million. The non-cash expenses of $19.0 million primarily included $13.7 million of depreciation and amortization expenses, $4.6 million of share-based compensation expense, and $0.7 million of deferred income taxes. The net changes in assets and liabilities of $40.1 million were primarily due to a $52.9 million increase in accrued and other liabilities, a $2.1 million increase in accounts payable due to timing of payments, and a $0.4 million increase in income taxes payable, partially offset by a $3.5 million increase in accounts receivable as a result of higher revenue, a $9.1 million increase in inventories due to a continued ramp of the JV Company, and a $2.6 million increase in other current and long-term assets due to increase in advance payments to suppliers.

Cash flows from investing activities

Net cash ~~provided by operating~~used in investing activities of ~~$9.8~~$40.0 million for the three months ended September 30, ~~2020 resulted~~2022 was primarily ~~from net income~~attributable to $40.3 million purchases of ~~$8.8 million~~property and ~~non-cash expenses of $15.4 million,~~equipment, partially offset by ~~net changes in assets and liabilities using net cash of $14.3 million. The non-cash expenses of $15.4~~$0.3 million primarily included $12.5 million of depreciation and amortization expenses and $2.9 million of share-based compensation expense. The net changes in assets and liabilities using cash of $14.3 million were primarily duegovernment grants related to a $13.0 million increase in accounts receivable as a result of better-than-expected revenue, a $2.2 million increase in inventories due to a continued ramp of the JV Company, and a $1.0 million increase in other current and long-term assets due to increase in advance payments to vendors, and a $0.8 million decrease in accrued and other liabilities, partially offset by a $1.9 million increase in accounts payable due to timing of payments, and a $0.7 million increase in income taxes payable.

~~Cash flows from investing activities~~fixed assets.

Net cash used in investing activities of $23.9 million for the three months ended September 30, 2021 was primarily attributable to purchases of property and equipment of $8.4 million for the JV Company and purchases of property and equipment of $16.6 million for other than the JV Company, net of government grants of $1.1 million.

Cash flows from financing activities

Net cash used in ~~investing~~financing activities of ~~$11.3~~$5.5 million for the three months ended September 30, ~~2020~~2022 was primarily attributable to ~~$11.3~~$8.6 million ~~purchases~~proceeds from borrowings, partially offset by $2.6 million in repayments of ~~property~~borrowings, $0.2 million in payment of finance lease obligations, and ~~equipment, including $3.4~~$0.4 million ~~purchased by the JV Company.~~

~~Cash flows from financing activities~~

in common shares acquired to settle withholding tax related to vesting of restricted stock units.

Net cash used in financing activities of $6.5 million for the three months ended September 30, 2021 was primarily attributable to $9.7 million in repayments of borrowings, $4.2 million in payment of finance lease obligations, and $0.2 million in common shares acquired to settle withholding tax related to vesting of restricted stock units, partially offset by $7.6 million proceeds from borrowings.

Net cash used in financing activities of $4.2 million for the three months ended September 30, 2020 was primarily attributable to $11.1 million in repayments of borrowings, $4.0 million in payment of finance lease obligations, and $0.4 million in common shares acquired to settle withholding tax related to vesting of restricted stock units, partially offset by $11.3 million proceeds from borrowings.

Commitments

See Note 1012 of the Notes to the Condensed Consolidated Financial Statements contained in this Quarterly Report on Form 10-Q for a description of commitments.

Off-Balance Sheet Arrangements

As of September 30, ~~2021,~~2022, we had no ~~material~~ off-balance sheet ~~arrangements as defined in Regulation S-K 303(a)(4)(ii)~~ arrangements.

Contractual Obligations

There were no material changes outside of our ordinary course of business in our contractual obligations from those disclosed in our Annual Report on Form 10-K for the fiscal year ended June 30, ~~2021.~~2022.

Recent Accounting Pronouncements

See Note 1 of the Notes to the Condensed Consolidated Financial Statements contained in this Quarterly Report on Form 10-Q for a description of recent accounting pronouncements, including the expected dates of adoption and estimated effects on results of operations and financial condition, which is incorporated herein by reference.

4041

ITEM 3. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK

There have been no material changes in the market risks previously disclosed in Part II, Item 7A, "Quantitative and Qualitative Disclosures About Market Risk," of our Annual Report on Form 10-K for the year ended June 30, ~~2021,~~2022, filed with the SEC on ~~August 30, 2021.~~September 19, 2022.

ITEM 4. CONTROLS AND PROCEDURES

Management's Evaluation of Disclosure Controls and Procedures

Our management, with the participation of our Chief Executive Officer and Chief Financial Officer, evaluated the effectiveness of our disclosure controls and procedures (as defined in Rules 13a-15(e) and 15d-15(e) under the Securities Exchange Act of 1934, as amended, (the “Exchange Act”)), as of the end of the period covered by this report. Based on that evaluation, the Chief Executive Officer and Chief Financial Officer concluded that our disclosure controls and procedures as of September 30, ~~2021~~2022 have been designed and are functioning effectively to provide reasonable assurance that the information required to be disclosed in the reports that we file or submit under the Exchange Act is recorded, processed, summarized and reported, within the time periods specified in the SEC’s rules and forms, and that such information is accumulated and communicated to our management, including our Chief Executive Officer and Chief Financial Officer, or persons performing similar functions, as appropriate to allow timely decisions regarding required disclosure.

Changes in Internal Control over Financial Reporting

There were no changes in our internal control over financial reporting during the three months ended September 30, ~~2021~~2022 that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.

Limitation on Effectiveness of Controls

While our disclosure controls and procedures and internal control over financial reporting are designed to provide reasonable assurance that their respective objectives will be met, we do not expect that our disclosure controls and procedures or our internal control over financial reporting are or will be capable of preventing or detecting all errors and all fraud. Any control system, no matter how well designed and operated, can provide only reasonable, not absolute, assurance that the control system's objectives will be met.

4142

PART II. OTHER INFORMATION

ITEM 1. LEGAL PROCEEDINGS

As previously disclosed, the DOJ commenced an investigation into the Company’s compliance with export control regulations relating to its business transactions with Huawei and its affiliates (“Huawei”), which were added to the “Entity List” by the DOC in May 2019. The Company is cooperating fully with federal authorities in the investigation. The Company has continued to respond to inquiries and requests from DOJ for documents and information relating to the investigation, and the matter is currently pending at DOJ, and DOJ has not provided the Company with any specific timeline or indication as to when the investigation will be concluded or resolved. In connection with this investigation, DOC previously requested the Company to suspend shipments of its products to Huawei. The Company complied with such request, and the Company has not shipped any product to Huawei after December 31, 2019. The Company continues to work with DOC to resolve this issue and requested DOC to grant permission to reinstate the Company’s shipments to Huawei. As part of this process and in response to DOC’s request, the Company provided certain documents and materials relating to the Company’s supply chain and shipment process to DOC, and DOC is currently reviewing this matter. DOC has not informed the Company of any specific timeline or schedule under which DOC will provide a response to the Company’s request.

On March 19, 2020, Darryl Gray, a stockholder of the Company (the “Plaintiff”), filed a putative class action complaint in the United States District Court for the Southern District of New York (the “Gray Action”), alleging that the Company and its management members made material misstatements or omissions regarding the Company’s business and operations, including its export control practices relating to business transactions with Huawei and its affiliates. The Gray Action asserts claims under Section 10(b) of the Exchange Act against the Company, its Chief Executive Officer and Chief Financial Officer (collectively, the Defendants”), as well as claims under Section 20(a) of the Exchange Act against the Chief Executive Officer and Chief Financial Officer. Among other remedies, the Gray Action seeks to recover compensatory and other damages as well as attorney’s fees and costs.

On May 18, 2020, Plaintiff moved for an order appointing him as Lead Plaintiff pursuant to Section 21D of the Exchange Act and approving Glancy Prongay & Murray LLP as Lead Counsel for the putative class (the “Motion”). On July 1, 2020, the Court entered an order granting the Motion and requiring that: (i) Lead Plaintiff file an amended complaint or designate the current complaint as operative within sixty days; (ii) Defendants answer the complaint or otherwise move within sixty days of such filing or designation; (iii) Lead Plaintiff file an opposition, if any, within 45 days; and (iv) Defendants file a reply, if any, forty-five days thereafter. On August 28, 2020, Plaintiff filed an amended complaint asserting the same claims against the Defendants, and adding the Company’s Executive Vice President of Product Line as a defendant on both claims. On October 27, 2020, the Defendants moved to dismiss the action in its entirety. Plaintiff filed his opposition on December 11, 2020 and Defendants filed their reply brief on January 25, 2021. On September 27, 2021, the Court entered an opinion and order granting Defendants’ motion and dismissing the amended complaint in its entirety. In so doing, the Court found, among other things, that Plaintiff failed adequately to allege that any of AOS’s indirect sales to Huawei were illegal, and therefore none of the Company’s statements regarding its positive performance or its efforts to contend with a difficult geopolitical climate and trade tensions could plausibly be seen as “inaccurate, incomplete, or misleading.” The Court’s order allowed Plaintiff an opportunity to file a second amended complaint by October 27, 2021, attempting to cure the various deficiencies, barring which the matter would be dismissed with prejudice. As of that date, however, no such filing was made and the Company anticipates that the matter will be dismissed with prejudice.

We have in the past, and may from time to time in the future, become involved in legal proceedings arising from the normal course of business activities. The semiconductor industry is characterized by frequent claims and litigation, including claims regarding patent and other intellectual property rights as well as improper hiring practices. Irrespective of the validity of such claims, we could incur significant costs in the defense thereof or could suffer adverse effects on its operations.

ITEM 1A. RISK FACTORS

Item 1A of Part I of our Annual Report on Form 10-K for the year ended June 30, 2020, filed with the SEC on ~~August 30, 2021,~~September 19, 2022, contains risk factors identified by the Company. ~~Except as noted below, there~~There have been no material changes to the risk factors we previously disclosed in our filings with the SEC. ~~Our operations could also be affected by additional factors that are not presently known to us or by factors that we currently consider immaterial to our business.~~

~~Disruptions, damages or destructions to our manufacturing facilities, machinery and equipment may materially and adversely affect our business operations~~

The success of our business depends on the continuing operations of our Oregon fab and our Chongqing fabrication facility operated by the JV Company. The operations of our fabrication facilities may be affected by various factors, including: (i) fire, flood or power failure at our production facilities or the buildings adjacent to our production sites; (ii) breakdown of machinery and equipment at our production facilities; or (iii) scheduled maintenance of our machinery and equipment. The occurrence of any unanticipated or prolonged disruptions, damage or destruction to our production facilities and machinery and equipment may affect our ability to produce and deliver products to our customers in a timely manner, which may adversely affect our business operation and financial results.

Our operations at our Chongqing fabrication facility operated by the JV Company are subject to operational risks, including but not limited to disruption of water or power supply and breakdown or malfunction of our machinery, which could result in delay, temporary suspension, permanent, partial or complete shut-downs of our production. For example, the recent electric power shortage in China prompted some local government to impose rationing of power supply that may result in factory shutdown due lack of continuous supply of electrical power. Additionally, local governments in certain provinces in China have raised prices or extended peak-demand periods during which prices are higher to address the issue and others have announced plans to do so in the future, which could increase the cost of power supplies.

Although our Chongqing fabrication facility has not experienced significant power supply disruption and is currently not subject to rationing of power supply, we cannot assure you that the government authorities will not enforce power restriction or shutdowns on the facility in the future. In the event that we become subject to such restrictions, we may be required to suspend or cease the production activities which may adversely affect our production schedule and the ability to fulfill the customer’s orders which in turn, adversely affect our business and financial condition. In addition, as a result of disruption to our operations, our production volume and the utilization rate of our production plants may be affected, which may result in a drop in our gross profit margin and profitability.

ITEM 2. UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS

In September 2017, the Board of Directors approved a repurchase program (the “Repurchase Program”) that allowed us to repurchase our common shares from the open market pursuant to a pre-established Rule 10b5-1 trading plan or through privately negotiated transactions up to an aggregate of $30.0 million. The amount and timing of any repurchases under the Repurchase Program depend on a number of factors, including but not limited to, the trading price, volume and availability of our common shares. There is no guarantee that such repurchases under the Repurchase Program will enhance the value of our shares. Shares repurchased under this program are accounted for as treasury shares and the total cost of shares repurchased is recorded as a reduction of shareholders' equity. During the three months ended September 30, ~~2021,~~2022, we did not repurchase any shares under the Repurchase Program. As of September 30, ~~2021,~~2022, approximately $13.4 million remained available under the Repurchase Program.

ITEM 3. DEFAULTS UPON SENIOR SECURITIES

Not applicable.

ITEM 4. MINE SAFETY DISCLOSURES

Not applicable.

ITEM 5. OTHER INFORMATION

Not applicable.

ITEM 6. EXHIBITS


~~10.1~~			~~Amended and Restated Director Compensation Policy~~
31.1			Certification of Chief Executive Officer pursuant to Securities Exchange Act Rules 13a-14(a) and 15d-14(a), as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
31.2			Certification of Chief Financial Officer pursuant to Securities Exchange Act Rules 13a-14(a) and 15d-14(a), as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
32.1			Certification of Chief Executive Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.
32.2			Certification of Chief Financial Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.
101.INS			Inline XBRL Instance
101.SCH			Inline XBRL Taxonomy Extension Schema
101.CAL			Inline XBRL Taxonomy Extension Calculation
101.DEF			Inline XBRL Taxonomy Extension Definition
101.LAB			Inline XBRL Taxonomy Extension Labels
101.PRE			Inline XBRL Taxonomy Extension Presentation
104			Cover Page Interactive Data File (formatted as inline XBRL and contained in Exhibit 101)

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

November ~~5, 2021~~7, 2022


ALPHA AND OMEGA SEMICONDUCTOR LIMITED

By:			/s/ YIFAN LIANG
			Yifan Liang
			Chief Financial Officer and Corporate Secretary
			(Principal Financial Officer)